<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy - Al-aqeel, S - 2020 | Cochrane Library</title> <meta content="Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy - Al-aqeel, S - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008312.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy - Al-aqeel, S - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008312.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008312.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy" name="citation_title"/> <meta content="Sinaa Al-aqeel" name="citation_author"/> <meta content="King Saud University" name="citation_author_institution"/> <meta content="salageel@ksu.edu.sa" name="citation_author_email"/> <meta content="Olga Gershuni" name="citation_author"/> <meta content="CAPHRI Care and Public Health Research Institute, Maastricht University" name="citation_author_institution"/> <meta content="Jawza Al-sabhan" name="citation_author"/> <meta content="King Saud University" name="citation_author_institution"/> <meta content="Mickael Hiligsmann" name="citation_author"/> <meta content="CAPHRI Care and Public Health Research Institute, Maastricht University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD008312.pub4" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/10/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008312.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008312.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008312.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticonvulsants [*therapeutic use]; Bias; Cost-Benefit Analysis; Epilepsy [*drug therapy, psychology]; Medication Adherence [*psychology]; Quality of Life; Randomized Controlled Trials as Topic; Self Efficacy" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008312.pub4&amp;doi=10.1002/14651858.CD008312.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="7LavyS58";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008312\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008312\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","ko","th","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008312.pub4",title:"Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy",firstPublishedDate:"Oct 22, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Epilepsy Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008312.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008312.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008312.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008312.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008312.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008312.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008312.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008312.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008312.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008312.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4942 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008312.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0036"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/appendices#CD008312-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#CD008312-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Sinaa Al-aqeel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#CD008312-cr-0005">Olga Gershuni</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#CD008312-cr-0006">Jawza Al-sabhan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information#CD008312-cr-0007">Mickael Hiligsmann</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information/en#CD008312-sec-0082">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 October 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008312.pub4">https://doi.org/10.1002/14651858.CD008312.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008312-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008312-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008312-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008312-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008312-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008312-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008312-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD008312-abs-0008">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008312-abs-0001" lang="en"> <section id="CD008312-sec-0001"> <h3 class="title" id="CD008312-sec-0001">Background</h3> <p>Poor adherence to antiepileptic medication is associated with increased mortality, morbidity and healthcare costs. In this review, we focus on interventions designed and tested in randomised controlled trials (RCTs) and quasi‐RCTs to assist people with adherence to antiepileptic medication. This is an update of a Cochrane review first published in 2011, and last updated in 2017. </p> </section> <section id="CD008312-sec-0002"> <h3 class="title" id="CD008312-sec-0002">Objectives</h3> <p>To determine the effectiveness of interventions aimed at improving adherence to antiepileptic medication in adults and children with epilepsy. </p> </section> <section id="CD008312-sec-0003"> <h3 class="title" id="CD008312-sec-0003">Search methods</h3> <p>For the latest update, we searched the following databases on 18 February 2020: Cochrane Register of Studies (CRS Web), MEDLINE, CINAHL Plus and PsycINFO. CRS Web includes RCTs or quasi‐RCTs from PubMed, Embase, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (ICTRP), CENTRAL, and the Specialized Registers of Cochrane Review Groups including Epilepsy. We also searched the reference lists of relevant articles. </p> </section> <section id="CD008312-sec-0004"> <h3 class="title" id="CD008312-sec-0004">Selection criteria</h3> <p>RCTs and quasi‐RCTs of adherence‐enhancing interventions aimed at people with a clinical diagnosis of epilepsy (as defined in individual studies), of any age and treated with antiepileptic drugs in a primary care, outpatient or other community setting. </p> </section> <section id="CD008312-sec-0005"> <h3 class="title" id="CD008312-sec-0005">Data collection and analysis</h3> <p>All review authors independently assessed lists of potentially relevant citations and abstracts. At least two review authors independently extracted data and performed a quality assessment of each study according to the Cochrane tool for assessing risk of bias. We graded the level of evidence for each outcome according to GRADE. The studies differed widely according to the type of intervention and measures of adherence; therefore combining data was not appropriate. </p> </section> <section id="CD008312-sec-0006"> <h3 class="title" id="CD008312-sec-0006">Main results</h3> <p>We included 20 studies reporting data on 2832 participants. Thirteen studies targeted adults with epilepsy, one study included participants of all ages, one study included participants older than two years, one recruited pediatric patients aged between 1 month to 15 years, one study targeted caregivers of children with epilepsy, one targeted adolescents and caregivers, and two studies targeted families of children with epilepsy. We identified three ongoing studies. Follow‐up time was generally short in most studies, ranging from 1 to 12 months. The studies examined three main types of interventions: educational interventions, behavioural interventions and mixed interventions. All but three studies compared treatment with usual care or 'no intervention'. Due to heterogeneity between studies in terms of interventions, methods used to measure adherence and the way the studies were reported, we did not pool the results and these findings were inappropriate to be included in a meta‐analysis. </p> <p>Education and counselling of participants with epilepsy had mixed success (moderate‐certainty evidence). Behavioural interventions such as the use of intensive reminders provided more favourable effects on adherence (moderate‐certainty evidence). The effect on adherence to antiepileptic drugs described by studies of mixed interventions showed improved adherence in the intervention groups compared to the control groups (high‐certainty evidence). </p> <p>Eleven studies described seizure frequency or seizure severity or both, with four of them, reporting improved adherence and decreased seizure frequency in the intervention groups (moderate‐certainty evidence). Findings related to self‐efficacy and quality of life were mixed, with no clear pattern across types of intervention. </p> </section> <section id="CD008312-sec-0007"> <h3 class="title" id="CD008312-sec-0007">Authors' conclusions</h3> <p>Behavioural interventions such as intensive reminders and the use of mixed interventions demonstrate some positive results, however, we need more reliable evidence on their efficacy, derived from carefully‐designed RCTs before we can draw a firm conclusion. None of the newly included studies have provided additional information that would lead to significant changes in our conclusions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008312-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008312-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008312-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008312-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008312-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD008312-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008312-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008312-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008312-abs-0016">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD008312-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD008312-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008312-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008312-abs-0002" lang="en"> <h3>What is the best way to ensure people with epilepsy take their medication as prescribed?</h3> <p><b>Why is this question important?</b><br/>Epilepsy is a very common condition that affects the brain. People with epilepsy experience seizures ‐ or fits ‐ that can affect their daily lives. They are often prescribed medicines to control or prevent seizures. People with epilepsy can find it difficult to take their medicines as prescribed, and this is thought to be a reason for poor control of seizures. This review of studies reports on ways of improving how they take their antiepileptic medication. </p> <p><b>What we did</b><br/>We searched medical databases for clinical studies looking at ways of improving adherence to medication in people with epilepsy. We limited our search to randomised controlled trials (RCTs) involving people with a clinical diagnosis of epilepsy of any age and treated with antiepileptic drugs in a primary care (for example, doctor's surgery), outpatient or other community setting. RCTs are medical studies where people are chosen at random to receive a treatment (called the intervention group) or to receive a different treatment or no treatment (called the control group). This type of study provides the most reliable evidence about whether different approaches to health care make a difference. </p> <p>The results are up to date to February 2020.</p> <p><b>What we found</b><br/>We identified 20 studies (2832 participants). The studies were conducted in different countries with the majority from the USA. The studies examined three main types of interventions: </p> <p>1. education and counselling of participants about topics such as epilepsy and medication used to control epilepsy (4 studies); </p> <p>2. behavioural interventions, such as asking people with epilepsy to link the intention of taking their medication with a particular time, place and other routine activity (13 studies); and </p> <p>3. mixed interventions, which is the use of more than one intervention (4 studies).</p> <p>One study is counted twice because it compared a behavioural intervention with a mixed intervention. </p> <p>Studies measured adherence to medication in various ways, for example, with questionnaires, blood samples or electronic bottle tops. Studies also measured reduction in frequency or severity of seizures to see if taking medication as prescribed made a difference. The studies were all very different from each other, so we could not combine their results. </p> <p><b>Key results and reliability of the evidence</b><br/>Education and counselling interventions may improve medication adherence. Two studies showed improvement, one study showed a small improvement and one no improvement. </p> <p>Behavioural and mixed interventions probably improve adherence to medication. People in the intervention groups showed improved adherence compared to the control groups. </p> <p>Four studies showed that when adherence improved in the intervention groups, seizure frequency or seizure severity was decreased. </p> <p>We were unable to draw firm conclusions about the results because the studies were very different from each other and did not always use the best methods. This means we are not certain about their evidence. </p> <p><b>What should happen next?</b><br/>We need carefully‐designed randomised controlled studies involving more people with longer follow‐up periods to identify the best intervention to improve adherence to antiepileptic medication. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008312-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008312-sec-0069"></div> <h3 class="title" id="CD008312-sec-0070">Implications for practice</h3> <section id="CD008312-sec-0070"> <p>Despite the increasing number of studies indicating that poor adherence to antiepileptic medication is common and is associated with increased morbidity and mortality, the literature concerning interventions to improve medication adherence in epilepsy is still limited in quantity and quality. Behavioural interventions and mixed interventions demonstrate some positive results; however, we are unable to draw firm conclusions regarding the long‐term effects of these interventions. </p> </section> <h3 class="title" id="CD008312-sec-0071">Implications for research</h3> <section id="CD008312-sec-0071"> <p>The results of our review highlight gaps in research on the effectiveness of interventions aimed at improving adherence to antiepileptic medication. Our findings emphasise the need for further adequately‐powered randomised controlled trials (RCTs) that use a combination of adherence measurement techniques and that provide participant follow‐up for a longer period. The differences between subjective self‐reporting and objective blood tests are difficult to resolve in order to report firm conclusions. Studies should investigate the effects of interventions on adherence, as well as important clinical outcomes such as seizures. Researchers should minimise the risks of bias by using suitable randomisation techniques, concealment of allocation and blinding of both healthcare providers and outcome assessors. Differences in medical systems between countries are another implication, as low‐ and middle‐income countries face many difficulties and limited possibilities to apply hospital‐based results to the general population, even within the same country. </p> <p>Patients' beliefs and preferences are prevalent influences on the medicine‐taking process (<a href="./references#CD008312-bbs2-0062" title="RandCS , SevickMA . Ethics in adherence promotion and monitoring. Controlled Clinical Trials2000;21(5 Suppl):241S-7S. [DOI: 10.1016/s0197-2456(00)00085-4] [PMID: 11018582]">Rand 2000</a>; <a href="./references#CD008312-bbs2-0069" title="SieberWJ , KaplanRM . Informed adherence: the need for shared medical decision making. Controlled Clinical Trials2000;21(5 Suppl):233S-40S. [DOI: 10.1016/s0197-2456(00)00084-2] [PMID: 11018581]">Sieber 2000</a>). One of the studies included in this review describes major limitations introduced by negative stereotypes about the medication treatment, and strong beliefs in traditional healing. Qualitative research involving people with epilepsy is of value in developing adherence‐enhancing interventions, in evaluating the validity of the content of these interventions, and in assessing their feasibility. This can be regarded as a foundational step before these interventions are tested in RCTs. </p> <p>Finally, the impact of adherence‐enhancing interventions on resource utilisation and its cost effectiveness merit further research. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008312-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008312-sec-0008"></div> <div class="table" id="CD008312-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults and children with epilepsy<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> adherence‐enhancing intervention<br/><b>Comparison:</b> no intervention or other intervention </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no intervention or other intervention</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with adherence‐enhancing intervention</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (behavioural interventions)</b><br/>Assessed with MEMS caps, self‐reported Antiretroviral General Adherence Scale (AGAS), the serum level and the Medication Adherence Report Scale (MARS)<br/>Follow‐up: range 1 month to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>391<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies showed significant improvement in adherence (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). 1 study showed minimal adherence improvements by the end of the follow‐up in combination with high levels of baseline adherence. Due to different interventions and assessment methods we are unable to draw further conclusions. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (educational interventions)</b><br/>Assessed with serum or plasma concentration, Medication Adherence Scale (MAS), MEMS, TrackCap and a 10‐item subscale from ‘Epilepsy Self‐management Scale’, the Morisky Medication Adherence Scale (MMAS‐8).<br/>Follow‐up: range 4 weeks to 13 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1938<br/>(13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 5 studies presented significant results of improved adherence. 1 study included families (the information on the total number of people is not specifically mentioned). Due to different interventions and assessment methods, we are unable to draw further conclusions (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (mixed interventions)</b><br/>Assessed with serum or plasma concentration, Medication Adherence Scale (MAS), MEMS, and Medication Adherence Scale (MARS‐5)<br/>Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>612<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>b</sup><br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 studies reported significant improvement in adherence. Due to heterogeneity of interventions and assessment methods, we are unable to draw further conclusions (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Seizure frequency and/or seizure severity</b> </p> <p>Assessed by National Hospital Seizure Severity Scale (NHS3), seizure diary and self‐reporting<br/>Follow‐up: range 4 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2147<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased seizure frequency and/or seizure severity related to improved adherence to AEDs was described in 4 out of 11studies presenting this secondary outcome. 2 studies reported improvement, however, no significant difference between 2 groups was reported or showed any changes. </p> <p>In 1 study, the intervention was associated with a stronger impact on self‐efficacy and seizure management (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐efficacy</b><br/>Assessed with the Epilepsy Self‐Efficacy Scale (ESES), General Self‐Efficacy Scale (GSES) and Sherer's Self‐Efficacy Scale<br/>Follow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>453<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>a,c</sup><br/>Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study presented significantly important results supporting improvement in self‐efficacy skills. Other studies reporting positive effects as a result of an intervention with mixed reliability (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b><br/>Assessed with Quality of Life in Epilepsy Scale (QOLIE‐10, QOLIE‐31‐P) and </p> <p>health‐related quality</p> <p>of life (HRQOL)</p> <p>Follow‐up: range 4 months to 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1027<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study reported significant benefit in the intervention group. 3 studies showed that there were no statistically significant differences and another study failed to present results supporting the added value of an intervention. Another study tried to evaluate HRQoL and to discuss relationships with other related outcomes: patients with lower QoL values were reporting lower levels of general well being and satisfaction. (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AED:</b> antiepileptic drug; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>MEMS:</b> Medication Event Monitoring System; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The certainty of the evidence of the studies measuring this outcome was downgraded due to the lack of precision or lack of consistency, or both.<br/><sup>b</sup>The majority of studies measuring this outcome were not at high risk of bias.<br/><sup>c</sup>The certainty of the evidence of the studies measuring this outcome was downgraded due to the lack directness. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008312-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">1.</span> <span class="table-title">Summary of results for each included study</span></div> <tbody> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Behavioural interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants completed a 14‐page packet of self‐report measures. Adherence was measured with MEMS cap. To assess the equivalence of control and intervention groups, and to identify factors that could moderate the impact of the intervention, a collection of self‐report measures was applied (methods such as a single‐item self‐estimate of the number of missed doses during the preceding month, BIPQ, TPB, MASQ, HADS, PRMQ, LSSS were administered at baseline and at follow‐up. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANOVA and Chi<sup>2</sup> test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention participants showed improved adherence relative to controls on all 3 outcomes: doses taken in total (93.4% vs 79.1%), days on which correct dose was taken (88.7% vs 65.3%), and doses taken on schedule (78.8% vs 55.3%); P &lt; 0.01 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using MEMS cap and self‐reported medication adherence via AGAS (at baseline and follow‐up assessment). The following scales were also used: ESMS (follow‐up assessment only), ESES, and knowledge about epilepsy measured by EKQ. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Independent t‐test used to compare treatment and control group on variables assessed at follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prescribed doses taken overall in the intervention group was 81.29% (SD 13.48) and doses taken on schedule 53.27% SD (17.74). The results for adherence and self‐efficacy were in the correct direction and statistically significant only at the 0.10 level, suggesting that the intervention may also improve confidence in self‐management </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MEMS TrackCap (Aardex Corporation). The cap contains a microchip to register the dates and times the bottle is opened and closed. </p> <p>For families using a pill box, adolescents were asked to use a The SimpleMed + to administer AED. When a compartment is opened a date/time stamp is sent wirelessly to a secure website, which was accessed by study staff. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hierarchical linear modelling (HLM)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The results are not reported clearly, but it appears that there were high levels of baseline adherence and minimal adherence improvements among all groups. Group 4 demonstrated lower overall adherence compared to all groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The primary outcomes were adherence to prescribed AEDs, assessed with serum level and the MARS. </p> <p>QoL and several psychosocial variables were also measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The linear mixed models (PROCMIXED) for continuous outcome variables.</p> <p>As serum level was a binary outcome, a logistic mixed model was conducted to assess the intervention effects on the serum level in patient groups between the two arms. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a progressive increase in average MARS in the intervention group, but no change was observed in the standard care group. Patients in the intervention group reported significantly higher medication adherence compared with those in the active comparator group at 3‐month (β = 4.6, p b 0.001) and 6‐month (β = 1.73, p b 0.001) follow‐up. </p> <p>The ORs of serum level were increased by 1.35 in participants in the intervention group (OR 1.35, 95% CI 1.07 to 1.71; P = 0.03) compared with those in the active comparator group at 3 months' follow‐up. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Educational interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug adherence and self‐care were measured respectively using the modified MMAS and the ESES. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistical analysis was carried out using SPSS software (version 16 for Windows), a paired t‐test was applied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the intervention group, the pre‐test mean MMAS score was 6.58, whereas the post‐test mean MMAS score was 7.53; the difference was significant (P = 0.001). The mean MMAS scores for the control group's pre‐test and post‐test were 6.46 and 6.58 respectively, which were not significantly different (P = 0.224). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence was measured using the MAS 8‐item measurement of self‐reported medication‐taking behaviours; perceived stress was measured by PSS and the ESI‐R. </p> <p>PSQI, ESMS, ESES, EKP and QOLIE‐10 measurements were also assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeated ANOVA measures were conducted using SPSS version 18.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trends toward statistical significance were noted for medication adherence (P = 0.118), stress (P = 0.098), self‐management (P = 0.098), and knowledge (P = 0.077). Participants who completed WebEase modules (intervention group) reported an increase in self‐efficacy (P = 0.013), meaning that they were more positive about their ability to manage medication, stress, or sleep issues. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seizure frequency: seizure diary</p> <p>Psychological morbidity and HRQoL: SF‐12</p> <p>Subjective well‐being: SWLS</p> <p>Resilience: CD‐RISC</p> <p>Adherence: MMAS‐8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before and after scores were compared using repeated ANOVA measures. Analyses of covariances were conducted on each of the outcomes, measured at time point 2, using groups as the controlling variable and controlling for baseline values recorded at time point 1. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The baseline versus after the intervention adherence score was 2.05 (SD 1.45) versus 1.72 (SD 1.99) in CG and 1.65 (SD 1.80) versus 1.76 (SD 1.64) in IG; P= 0.376. The difference in mean change scores (95% CI) was reported as –0.388 (–1.27, 0.493); P= 0.376. The mean seizure occurrences between the control and intervention groups were 12.71 (SD 24.55) and 6.76 (SD 13.40). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood test measuring serum drug level was used to assess adherence with medication. The following measurements were also performed: level of anxiety was assessed by STAI, WPSI, AD scale, Sherer’s Self‐Efficacy Scale and epilepsy knowledge and medical management 50‐item true‐false questionnaire </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeated ANOVa measures and a series of paired t‐tests</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percentage change scores in blood AED levels (adherence) in the intervention group increased significantly F(1,24) = 4.18, P &lt; 0.05. The treatment group showed a significant decrease in level of fear of death and brain damage due to seizures, F(1,36) = 7.49 (P = 0.009) and a significant decrease in hazardous medical self‐management practices, F(1,36) = 29.67 (P = 0.0001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in adherence to AEDs was assessed by self‐report using the 4‐item MMAS. Plasma drug concentrations were measured using a fluorescence polarisation immunoassay analyser (TDxFLx Abbott Laboratories)<br/>Epilepsy beliefs were measured using KEBAS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pearson’s Chi<sup>2</sup> test, modified Poisson regression t‐tests and logistic regression. All statistical analyses were performed using STATA (version 12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference in adherence to AEDs was noted between the 2 groups based on self‐reports (OR 1.00, 95% CI 0.71 to 1.40; P = 1.00) or in detectable drug levels (OR 1.46, 95% CI 0.74 to 2.90; P = 0.28). No difference in seizure frequency was found between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers completed baseline questionnaires and all families were provided with MEMS‐6 Track‐Cap to monitor adherence. Caregivers (intervention group) also completed several questionnaires: psychosocial (e.g. QoL), epilepsy knowledge, social problem‐solving skills, epilepsy medication management, feasibility‐acceptability questionnaire, medical chart review and background information form </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Means, SDs and frequencies were measured using IBM SPSS statistics software (version 20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean percentage change in adherence from baseline to post‐intervention was 31.5 (SD 52.9) for the intervention group and 9.3 (SD 8.7) for the control group (no significance levels were reported). The impact on quality of life due to the implementation of the intervention reported a significant benefit (mean 6.75 (SD 0.6)). Other outcomes measured included assessment of feasibility and acceptability of the adherence intervention. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adherence, MEMS TrackCap (Aardex Corporation)</p> <p>For secondary outcomes: EKQ; Social Problem‐Solving Iventory‐Revised; Parent response to child illness </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A repeated‐measures model based on maximum likelihood estimation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence score (weeks 4–6; TAU = 12.0 vs STAR (intervention group) = 18.1, P &lt; 0.01; and weeks 6–8: TAU = 9.7 vs STAR = 15.3, P &lt; 0.05). During the 3‐month follow‐up period, no significant group differences were found on AED adherence. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum drug levels of phenobarbitone, phenytoin, carbamazepine, sodium valproate, and ethosuximide were performed using a gas liquid chromatograph or by the EMIT method on each occasion where relevant. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparisons of means in paired samples, Student’s t‐test, correlation coefficients, and linear regressions were performed using an IBM computer </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The results show whether information was given in oral form alone or both orally and in written form; adherence to drug treatment as measured by serum levels was not improved. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For QoL: QOLIE‐31‐P with added patient‐specific weightings.</p> <p>For adherence, Medication Adherence, a 10‐item subscale from ESMS</p> <p>Other outcomes assessed using seizure frequency scales, seizure recency (number of days since last seizure), HADS<br/>for psychological distress (anxiety and depression), Impact of Epilepsy, Stigma of Epilepsy, medication adverse effects extracted from the QOLIE‐31‐P, and self‐mastery and control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All outcomes were analysed using the ITT approach. Linear mixed regression model was used for analysis of primary and secondary outcomes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 12‐month follow‐up, the medication adherence score median (IQR) for intervention was 47.8 (IQR 45.6 to 48.9; range 27.8 to 50.0) versus 47.8 (IQR 45.6 to 48.9; range 35.6 to 50.0) in the TAU group. </p> <p>There were no statistically significant differences between trial arms in QOLIE‐31‐P (intervention mean 67.4, SD 13.5; control mean 69.5, SD 14.8). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using the MMAS‐8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pearson’s correlation, t‐test, Fisher Exact test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At baseline, the mean scores of knowledge questionnaire</p> <p>was lower in intervention (6.73) compared with control (7.48). After the video animation, intervention group mean score increased (7.42; P &lt; 0.001) and at the 3‐month follow‐up (7.47). There were slight score changes at 3‐time point in control group (7.48,7.53, 7.44). </p> <p>The proportion of participants with improved adherence was 54 (42.9%) in intervention versus 14 (15.9%) in control group P &lt; 0.001 </p> <p>Proportion of participants with improved severity of seizure higher in intervention 47 (37.3%) than control group 22 (25.0%) in CG, P = 0.14. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed by measurement of serum drug levels using blood tests</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANOVA, ANCOVA and Chi<sup>2</sup> tests were performed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean score of the intervention group on the combined adherence score was 2.9, which is significantly higher than the mean score in the control group 2.2 (F(1,48) = 6.36, P = 0.015). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed using MMAS‐8, other measures included Beck Depression Inventory, Beck Anxiety Inventory, QOLIE‐31 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>t<i>‐</i>test and Mann‐Whitney test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased number of participants with moderate‐to‐high AED adherence (71 (77.2%) vs 56 (60.9%); P =0.006). </p> <p>The intervention group showed improvements in 5 of the 7 subscales in QOLIE‐31, overall QoL (74.1 ± 15.0 vs 63.2 ± 14.6; P = 0.010), emotional well‐being (81.3 ± 16.2 vs 69.0 ± 15.5; P = 0.006), energy (74.8 ± 18.2 vs 63.4 ± 17.0; P = 0.013), cognitive function (77.7 ± 20.4 vs 66.5 ± 19.3; P = 0.011), and social function (72.0 ± 22.7 vs 61.8 ± 21.6; P = 0.015). The control group showed improvements in only 3 aspects; seizure worry (51.0 ± 32.7 vs 46.1 ± 30.0; P = 0.038), emotional well‐being (68.7 ± 22.1 vs 67.8 ± 21.1; P = 0.007), and medication effect (52.1 ± 36.3 vs 47.8 ± 34.4; P = 0.015). Proportion of participants with a low seizure frequency increased in both the intervention group (70 (76.1%) vs 41 (44.6%); (P= 0.001) and the control group (74 (80.4%) vs 50 (54.3%); P = 0.001) however, the difference between the 2 groups, is not significant (80.5% vs 76.1%; P = 0.475). A reduction of number of participants with severe depression and anxiety. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Mixed interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adherence, MEMS (Aardex) and MARS‐5.</p> <p>Other outcomes were self‐efficacy and general self‐efficacy (disease‐specific self‐efficacy (ESES and GSES), seizure severity NHS3); emotional well‐being (HADS); QoL (QOLIE‐31P); proactive coping (Utrecht Proactive Coping Competence); and side‐effects of antiepileptic drugs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The baseline differences between the multicomponent self‐management intervention group and TAU group were analysed using independent t‐tests </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with epilepsy lost to follow‐up or who did not use the cap at all, were considered nonadherent. Adherence rates of those included in the MEMS analysis over 6 months were 63.7% for the CAU group and 75.9% for the intervention group; the difference was not statistically significant. </p> <p>Adherence score over 6 months were 23.7 (1.3) for the CAU group and 23.9(0.9) for the intervention group; the difference was not statistically significant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To assess drug adherence, 6‐response‐option rating scales were applied. With regard to lifestyle or habits, 6 similar ratings were used to measure frequency of seizure‐provoking events. The subsequent seizure assessment for intervention group was obtained from the epilepsy tracking card. </p> <p>In control group medical adherence ratings were derived from self‐reported data and calculated AED adherence by counting the remaining pills to count the number of missed doses </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chi<sup>2</sup> test, or correlated Chi<sup>2</sup> test or Fisher’s exact test and one‐way ANOVA were used to conduct statistical analyses with SPSS (version 17.0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence improved in the intervention group, as most members (142 (77.6%) compared to 17 (9.6%)) rated their adherence as excellent or very good, but it remained nearly unchanged in the control group. </p> <p>A moderate correlation was found between the changes in AED adherence and seizure control (r = 0.4, P &lt; 0.05), and a weaker correlation was found between lifestyle and seizure control (r = 0.328, P &lt; 0.05). The percentage of participants reported a reduction in seizures in at least 50% (including those who were seizure‐free) rose to 79.8% in the intervention group, compared to 61.0% in the control group (P &lt; 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed by changes in plasma anticonvulsant levels (provided that the participant's medication regimen had not been altered in the preceding 2 weeks), a check of the participant's prescription record book to determine prescription refill frequency, medication seizure diary (to record Dosett container check) and participant appointment‐keeping frequency (those who had attended all scheduled appointments in the previous 6 months were considered compliant) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>McNemar tests for related samples, Wilcoxon matched‐pair tests, Stuart‐Maxwell tests, and Student’s paired t‐tests,<br/>Chi<sup>2</sup> tests, Mann‐Whitney tests, and Student’s unpaired t‐tests </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study shows that adherence (mean plasma levels) can be improved and seizure frequency lessened by compliance‐improving intervention. Although the differences between the 2 groups in mean anticonvulsant dosages were not statistically significant, they might be clinically important. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> </p> <p>(This study is presented in this review as both educational and mixed interventions)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using the</p> <p>MMAS‐4; seizure control was reported according to the participants’ records and telephone follow‐ups by the pharmacist; a questionnaire was developed to evaluate the level of each participant's knowledge of AEDs; QOLIE‐31 was used to measure QoL.<br/>Adherence, knowledge of AEDs, number of seizures and other measures were evaluated at the beginning and at the end of follow‐up. QoL was only measured after intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All analyses were performed using the IBM SPSS statistics (version 19). Tests such as Pearson's Chi<sup>2</sup> tests, student's t‐tests and Mann–Whitney U test were performed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The adherence and knowledge of AEDs increased greatly after intervention in all participants, the number of seizures and missed dosages also decreased. However, no significant differences were observed between 2 groups: increased adherence (62.3% vs 64.3%, P = 0.827); increased knowledge of AEDs (88.7% vs 80.4%, P = 0.231) and improved seizure control (64.2% vs 64.3%, P = 0.988). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>AD:</b> Acceptance of Disability; <b>AED:</b> antiepileptic drug; <b>AGAS:</b> Antiretrovial General Adherence Scale; <b>ANCOVA:</b> analyses of co‐variance; <b>ANOVA:</b> analysis of variance; <b>BIPQ:</b> Brief Illness Perception Questionnaire; <b>CD‐RISC:</b> Connor‐Davidson resilience scale; <b>CI:</b> confidence interval; <b>EKQ:</b> Epilepsy Knowledge Questionnaire; <b>EKP:</b> Epilepsy Knowledge Profile; <b>EMIT:</b> enzyme‐multiplied immunoassay technique; <b>ESES:</b> Epilepsy Self‐Efficacy Scale; <b>ESI‐R:</b> Revised Epilepsy Stressor Inventory; <b>ESMS:</b> Epilepsy Self‐Management Scale; <b>GSES:</b> General Self‐Efficacy Scale; <b>HADS:</b> Hospital Anxiety and Depression Scale; <b>HRQoL:</b> health‐related quality of life; <b>KEBAS:</b> Kilifi Epilepsy Beliefs and Attitudes Scores; <b>LSSS:</b> Liverpool Seizure Severity Scale; <b>MARS:</b> Medication Adherence Report Scale; <b>MAS:</b> Medication Adherence Scale; <b>MASQ:</b> Multiple Ability Self Report Questionnaire; <b>MEMS:</b> Medication Event Monitoring Systems; <b>MMAS:</b> Morisky Medication Adherence Scale; <b>NHS3:</b> National Hospital Seizure Severity Scale; <b>OR:</b> odds ratio; <b>PRMQ:</b> Prospective and Retrospective Memory Questionnaire; <b>PSQI:</b> Pittsburgh Sleep Quality Index; <b>PSS:</b> Perceived Stress Scale; <b>QoL:</b> quality of life; <b>QOLIE:</b> Quality of Life in Epilepsy Scale; <b>SD:</b> standard deviation; <b>SF‐12:</b> Short‐Form 12‐question health survey; <b>STAI:</b> State‐Trait Anxiety Inventory, State Annxiety Scale; <b>SWLS:</b> Satisfaction with Life Scale; <b>TAU:</b> treatment as usual; <b>TPB:</b> Theory of Planned Behaviour; <b>WPSI:</b> Washington Psychosocial Seizure Inventory </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008312-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008312-sec-0009"></div> <p>This is an update of a Cochrane review first published in 2011, and last updated in 2017 (<a href="./references#CD008312-bbs2-0075" title="Al‐aqeelS , GershuniO , Al‐sabhanJ , HiligsmannM . Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: CD008312. [DOI: 10.1002/14651858.CD008312.pub3]">Al‐aqeel 2017</a>). </p> <section id="CD008312-sec-0010"> <h3 class="title" id="CD008312-sec-0010">Description of the condition</h3> <p>The International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy define epilepsy as, "a disorder of the brain characterised by an enduring predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological and social consequences of this condition" (<a href="./references#CD008312-bbs2-0044" title="FisherRS , Van Emde BoasW , BlumeW , ElgerC , GentonP , LeeP , et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia2005;46(4):470-2. [PMID: 15816939]">Fisher 2005</a>). The definition of epilepsy requires the occurrence of at least one epileptic seizure. Epilepsy is one of the most common neurological disorders worldwide, with a prevalence estimated to be between 4 and 10 per 1000 people (<a href="./references#CD008312-bbs2-0065" title="SanderJW . The epidemiology of epilepsy revisited. Current Opinion in Neurology2003;16(2):165-70. [PMID: 12644744]">Sander 2003</a>). The systematic review by <a href="./references#CD008312-bbs2-0057" title="NgugiAK , KariukiSM , BottomleyC , KleinschmidtI , SanderJW , NewtonCR . Incidence of epilepsy. a systematic review and meta-analysis. Neurology2011;77(10):1005–12. [DOI: 10.1212/WNL.0b013e31822cfc90] [PMID: 21893672]">Ngugi 2011</a> presented the pooled incidence of epilepsy and included 33 relevant studies. The median incidence of epilepsy was 50.4 per 100,000 people per year and ranged from 30.3 to 66.7 per 100,000 people per year (median 45.0) in high‐income countries, and from 28.0 to 239.5 cases per 100,000 people per year (median 81.7) generally quoted for middle‐income countries. </p> <p>The term 'adherence' describes the extent to which a person takes their medication as prescribed with respect to dosage and dosing intervals (<a href="./references#CD008312-bbs2-0035" title="CramerJA , RoyA , BurrellA , Fairchild CJ, FuldeoreMJ , OllendorfDA , et al. Medication compliance and persistence: terminology and definitions. Value in Health2008;11(1):44-7. [DOI: 10.1111/j.1524-4733.2007.00213.x] [PMID: 18237359]">Cramer 2008</a>). Adherence is not the same as 'concordance', which includes a consensual agreement about treatment‐taking that is established between patient and practitioner (<a href="./references#CD008312-bbs2-0040" title="EatockJ , BakerGA . Managing patient adherence and quality of life in epilepsy. Neuropsychiatric Disease and Treatment2007;3(1):117-31. [PMID: 19300542]">Eatock 2007</a>). However, both terms are quantifiable parameters and both describe the dose quantity and the medication intake in general (<a href="./references#CD008312-bbs2-0072" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [DOI: 10.1111/j.1365-2125.2012.04167] [PMID: 22486599]">Vrijens 2012</a>). Adherence, as a process, includes three stages according to <a href="./references#CD008312-bbs2-0072" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [DOI: 10.1111/j.1365-2125.2012.04167] [PMID: 22486599]">Vrijens 2012</a>: initiation, implementation and discontinuation. </p> <p>Non‐adherence can be intentional, with patients acting in a certain way according to their own expectations of treatment, side effects and lifestyle choice; or non‐intentional, when patients do not adhere through forgetfulness, misunderstanding or uncertainty about clinicians' recommendations, which might result from a more passive behaviour. Non‐adherence to medication is a prevalent and persistent healthcare problem, particularly for people with a chronic disorder (<a href="./references#CD008312-bbs2-0053" title="LehaneE , McCarthyG . Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. International Journal of Nursing Studies2007;44(8):1468–77. [DOI: 10.1016/j.ijnurstu.2006.07.010] [PMID: 16973166]">Lehane 2006</a>). </p> <p>A few older studies (<a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>; <a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>), and one newer study (<a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>), included in this review used the term 'medication compliance', although the description of the outcome by the study authors is comparable with the term 'adherence' according to the new taxonomy (<a href="./references#CD008312-bbs2-0072" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [DOI: 10.1111/j.1365-2125.2012.04167] [PMID: 22486599]">Vrijens 2012</a>). </p> </section> <section id="CD008312-sec-0011"> <h3 class="title" id="CD008312-sec-0011">Description of the intervention</h3> <p>Interventions designed to enhance medication adherence include a simplified dosage regimen, combinations of more thorough patient instruction and counselling, (intensive) reminders, close follow‐up, supervised self‐monitoring, rewards for success, family therapy, psychological therapy and telephone follow‐up. </p> </section> <section id="CD008312-sec-0012"> <h3 class="title" id="CD008312-sec-0012">Why it is important to do this review</h3> <p>Of those people diagnosed with epilepsy, the vast majority are treated with antiepileptic drugs, and approximately 70% can become seizure‐free once the most effective regimen is followed (<a href="./references#CD008312-bbs2-0040" title="EatockJ , BakerGA . Managing patient adherence and quality of life in epilepsy. Neuropsychiatric Disease and Treatment2007;3(1):117-31. [PMID: 19300542]">Eatock 2007</a>). Unfortunately, evidence suggests that adherence to medication among people with epilepsy is suboptimal (<a href="./references#CD008312-bbs2-0034" title="BriesacherBA , AndradeSE , FouayziH , ChanKA . Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy2008;28(4):437-42. [DOI: 10.1592/phco.28.4.437] [PMID: 18363527]">Briesacher 2008</a>; <a href="./references#CD008312-bbs2-0037" title="DavisKL , CandrilliSD , EdinHM . Prevalence and cost of non adherence with antiepileptic drugs in an adult managed care population. Epilepsia2008;49(3):446-54. [PMID: 18031549]">Davis 2008</a>; <a href="./references#CD008312-bbs2-0041" title="EttingerAB , BakerGA . Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy &amp; Behavior2009;15 Suppl 1:S60-3. [PMID: 19303055]">Ettinger 2009a</a>; <a href="./references#CD008312-bbs2-0054" title="MalekN , HeathCA , GreeneJ . A review of medication adherence in people with epilepsy. Acta Neurologica Scandinavica2017;135(5):507–15. [DOI: 10.1111/ane.12703] [PMID: 27781263]">Malek 2017</a>). </p> <p>Poor adherence to antiepileptic drugs is associated with increased mortality, emergency department visits, hospitalisations, fractures and head injuries (<a href="./references#CD008312-bbs2-0037" title="DavisKL , CandrilliSD , EdinHM . Prevalence and cost of non adherence with antiepileptic drugs in an adult managed care population. Epilepsia2008;49(3):446-54. [PMID: 18031549]">Davis 2008</a>; <a href="./references#CD008312-bbs2-0042" title="EttingerAB , ManjunathR , CandrilliSD , DavisKL . Prevalence and cost of non adherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy &amp; Behavior2009;14(2):324-9. [PMID: 19028602]">Ettinger 2009b</a>; <a href="./references#CD008312-bbs2-0043" title="FaughtE , DuhMS , WeinerJR , GuerinA , CunningtonMC . Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology2008;71(20):1572-8. [PMID: 18565827]">Faught 2008</a>). Seizure risk is 21% higher among non‐adherers than adherers (<a href="./references#CD008312-bbs2-0055" title="ManjunathR , DavisKL , CandrilliSD , EttingerAB . Association of antiepileptic drug non adherence with risk of seizures in adults with epilepsy. Epilepsy &amp; Behavior2009;14(2):372-8. [PMID: 19126436]">Manjunath 2009</a>). Increased frequency of seizures can have serious repercussions on an individual's perceived quality of life (<a href="./references#CD008312-bbs2-0033" title="BakerGA , JacobyA , BuckD , StalgisC , MonnetD . Quality of life of people with epilepsy: a European study. Epilepsia1997;38(3):353-62. [PMID: 9070599]">Baker 1997</a>; <a href="./references#CD008312-bbs2-0050" title="HovingaCA , AsatoMR , ManjunathR , WhelessJW , PhelpsSJ , ShethRD , et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy &amp; Behavior2008;13(2):316-22. [DOI: 10.1016/j.yebeh.2008.03.009] [PMID: 18472303]">Hovinga 2008</a>). It appears also to be associated with increased utilisation and costs of inpatient and emergency services (<a href="./references#CD008312-bbs2-0037" title="DavisKL , CandrilliSD , EdinHM . Prevalence and cost of non adherence with antiepileptic drugs in an adult managed care population. Epilepsia2008;49(3):446-54. [PMID: 18031549]">Davis 2008</a>; <a href="./references#CD008312-bbs2-0042" title="EttingerAB , ManjunathR , CandrilliSD , DavisKL . Prevalence and cost of non adherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy &amp; Behavior2009;14(2):324-9. [PMID: 19028602]">Ettinger 2009b</a>; <a href="./references#CD008312-bbs2-0043" title="FaughtE , DuhMS , WeinerJR , GuerinA , CunningtonMC . Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology2008;71(20):1572-8. [PMID: 18565827]">Faught 2008</a>). </p> <p>To tackle the problem of non‐adherence, we need to identify the most effective adherence‐enhancing interventions and find out how well they improve adherence in people with epilepsy. Several systematic reviews published in the Cochrane Library have looked at adherence‐enhancing interventions. For instance, the <a href="./references#CD008312-bbs2-0059" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a> review included unconfounded randomised controlled trials (RCTs) of interventions to improve adherence with prescribed medication, measuring both medication adherence and clinical outcome (such as seizure frequency), with at least 80% follow‐up of each group studied and, for long‐term treatments, at least six months' follow‐up for studies with positive findings at earlier time points. Of all 182 RCTs identified, only 17 had the lowest risk of bias for study design features and their primary clinical outcome. Only five out of the 17 RCTs reported improvements in both adherence and clinical outcomes. The review identified one study looking at antiepileptic drugs, which reported improved medication adherence by combining a number of interventions such as counselling, a special medication container, self‐recording of medication intake and seizures, and mailed reminders to collect prescription refills and attend clinic appointments (<a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>). Another review of interventions to enhance antiepileptic drug adherence and clinical outcomes published in 2017 (<a href="./references#CD008312-bbs2-0036" title="da Mota GomesM , NavarroT , KeepanasserilA , JefferyR , HaynesRB . Increasing adherence to treatment in epilepsy: what do the strongest trials show?Acta Neurologica Scandinavica2017;135(3):266–72. [DOI: 10.1111/ane.12668] [PMID: 27573252]">da Mota Gomes 2017</a>), identified four studies included in our review (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>). </p> <p>Considering the burden of poor adherence to antiepileptic drugs, substantial efforts in adherence research and assessing whether these efforts have led to more effective interventions for epilepsy, an updated review is highly relevant. These gaps can be addressed by summarising new high‐quality evidence from RCTs to date. We have therefore updated our comprehensive systematic review, last published in 2017, by searching for recent studies published up to February 2020. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008312-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008312-sec-0013"></div> <p>To determine the effectiveness of interventions aimed at improving adherence to antiepileptic medication in adults and children with epilepsy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008312-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008312-sec-0014"></div> <section id="CD008312-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008312-sec-0016"> <h4 class="title">Types of studies</h4> <p>RCTs and quasi‐RCTs comparing adherence‐enhancing interventions versus no intervention or other intervention. </p> </section> <section id="CD008312-sec-0017"> <h4 class="title">Types of participants</h4> <p>The target population consisted of people with a clinical diagnosis of epilepsy (as defined in individual studies), of any age and of either gender, treated with antiepileptic drugs in a primary care, outpatient or other community setting. We examined interventions targeting all types of epilepsy. We excluded studies that examined people with epilepsy with neurological comorbidities, such as intellectual disabilities and behavioural problems. </p> </section> <section id="CD008312-sec-0018"> <h4 class="title">Types of interventions</h4> <p>Interventions of any type intended to increase adherence to antiepileptic medication. We considered interventions that were aimed at patients as well as at parents and caregivers, including but not exclusive to the following. </p> <p> <ul id="CD008312-list-0001"> <li> <p>Simplification of drug regimen</p> </li> <li> <p>Patient education and information</p> </li> <li> <p>Intensified patient care (increasing follow‐up, sending out reminders, etc.)</p> </li> <li> <p>Complex behavioural approach (increasing motivation by arranging group sessions, giving out rewards, etc.) </p> </li> </ul> </p> <p>Control groups should have received no intervention, another intervention or 'usual care'. </p> </section> <section id="CD008312-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD008312-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD008312-list-0002"> <li> <p>Improved adherence to medication (including any definition of adherence and noting how this was defined and measured in each study) </p> </li> </ul> </p> </section> <section id="CD008312-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD008312-list-0003"> <li> <p>Seizure frequency or seizure severity, as measured by the Liverpool Seizure Severity Scale or similar measure </p> </li> <li> <p>Treatment side effects</p> </li> <li> <p>Self‐efficacy</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Serious adverse events</p> </li> <li> <p>Costs or cost effectiveness of adherence‐modifying interventions</p> </li> </ul> </p> </section> </section> </section> <section id="CD008312-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008312-sec-0023"> <h4 class="title">Electronic searches</h4> <p>We ran the original search in June 2010. We ran subsequent searches in July 2012, February 2013, September 2014, September 2015, February 2016, and June 2018. </p> <p>For the latest update, we searched the following electronic databases on 18 February 2020: </p> <p> <ul id="CD008312-list-0004"> <li> <p>Cochrane Register of Studies (CRS Web), using the search strategy outlined in <a href="./appendices#CD008312-sec-0074">Appendix 1</a>. CRS Web includes RCTs or quasi‐RCTs from PubMed, Embase ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (ICTRP), the Cochrane Central Register of Controlled Trials (CENTRAL), and the Specialized Registers of Cochrane Review Groups including Epilepsy; </p> </li> <li> <p>MEDLINE (Ovid 1946 to 14 February 2020), using the search strategy outlined in <a href="./appendices#CD008312-sec-0075">Appendix 2</a>; </p> </li> <li> <p>CINAHL Plus (EBSCOhost 1937 onwards), using the search strategy outlined in <a href="./appendices#CD008312-sec-0076">Appendix 3</a>; </p> </li> <li> <p>PsycINFO (EBSCOhost 1887 onwards), using the search strategy outlined in <a href="./appendices#CD008312-sec-0077">Appendix 4</a>. </p> </li> </ul> </p> <p>Previously, review authors searched Embase (Ovid 1980 to June 2012) using the search strategy outlined in <a href="./appendices#CD008312-sec-0078">Appendix 5</a>; however, RCTs and quasi‐RCTs published in Embase are now included in CRS Web, so there was no longer any need to search Embase separately. </p> </section> <section id="CD008312-sec-0024"> <h4 class="title">Searching other resources</h4> <p>We screened the reference lists of all retrieved articles to identify additional publications.</p> </section> </section> <section id="CD008312-sec-0025"> <h3 class="title" id="CD008312-sec-0025">Data collection and analysis</h3> <section id="CD008312-sec-0026"> <h4 class="title">Selection of studies</h4> <p>All review authors independently assessed lists of potentially relevant citations and abstracts. Each review author indicated whether a citation was: </p> <p> <ul id="CD008312-list-0005"> <li> <p>relevant (meeting all prespecified inclusion criteria);</p> </li> <li> <p>possibly relevant (meeting some, but not all, inclusion criteria); or</p> </li> <li> <p>rejected (not relevant to the review; did not meet any of the inclusion criteria).</p> </li> </ul> </p> <p>We obtained articles classified in categories 1 and 2 in full, and at least two of the review authors reviewed them independently. The review authors reached their final decision by consensus, with disagreements resolved by discussion. </p> </section> <section id="CD008312-sec-0027"> <h4 class="title">Data extraction and management</h4> <p>At least two review authors independently extracted data from the full papers, with disagreements handled in the same way as for study selection. Extracted information included details of randomisation methods, demographics and clinical characteristics of each group, entry and exclusion criteria, number of participants excluded or lost to follow‐up, details of the intervention, baseline and post‐intervention results and methods of analysis. </p> <p>We kept records in the form of a 'Quality of reporting of meta‐analyses', or QUOROM, statement (<a href="./references#CD008312-bbs2-0056" title="MoherD , CookDJ , EastwoodS , OlkinI , RennieD , StroupDF . Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet1999;354(9193):1896-900. [PMID: 10584742]">Moher 1999</a>). </p> </section> <section id="CD008312-sec-0028"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the methodological quality of studies using the Cochrane 'Risk of bias' guidelines (<a href="./references#CD008312-bbs2-0049" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.">Higgins 2017</a>). We examined the following sources of bias. </p> <p> <ul id="CD008312-list-0006"> <li> <p>Selection bias: systematic differences between baseline characteristics of the groups compared </p> </li> <li> <p>Performance bias: systematic differences between groups in the care provided, or in exposure to factors other than the interventions of interest </p> </li> <li> <p>Attrition bias: systematic differences between groups in withdrawal from a study</p> </li> <li> <p>Detection bias: systematic differences between groups in how outcomes are determined</p> </li> <li> <p>Reporting bias: systematic differences between reported and unreported findings</p> </li> </ul> </p> </section> <section id="CD008312-sec-0029"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed interventions for adults independently from those aimed at children. We grouped studies according to types of interventions and compared outcomes independently of each other. </p> <p>For dichotomous outcomes (proportions of participants with improved adherence per group), we used the risk ratio (RR) as the summary statistic. For continuous data, we used the mean difference (MD) (when all studies reported the outcome using the same scale) or the standardised mean difference (SMD) (when studies used different scales). For all data, we computed 95% confidence intervals (CIs). </p> <p>If in the original reports participants were not analysed within the group to which they were randomly assigned, but information in the study report was sufficient, we attempted to restore participants to their correct group to allow an intention‐to‐treat analysis. </p> </section> <section id="CD008312-sec-0030"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors to ask for missing information and data.</p> </section> <section id="CD008312-sec-0031"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical (age, gender, epilepsy type and duration of epilepsy) and methodological (randomisation concealment, losses to follow‐up, adherence measurement and reporting) differences between studies. If a group of studies seemed to be similar enough to be pooled in meta‐analysis, we planned to assess statistical heterogeneity of pooled results by using the I<sup>2</sup> statistic (<a href="./references#CD008312-bbs2-0038" title="DeeksJJ , HigginsJP , Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Deeks 2019</a>; <a href="./references#CD008312-bbs2-0047" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [DOI: 10.1136/bmj.327.7414.557] [PMID: 12958120]">Higgins 2003</a>). However, due to clinical and methodological heterogeneity between identified studies, we did not perform statistical heterogeneity tests. </p> </section> <section id="CD008312-sec-0032"> <h4 class="title">Data synthesis</h4> <p>We undertook a quantitative analysis of all included studies. We summarised data statistically if they were available, were of sufficient quality and were sufficiently similar, and if we observed no important clinical and methodological heterogeneity. If no significant heterogeneity was present, we had planned to synthesise the data using a fixed‐effect model; otherwise we used a random‐effects model. We performed statistical analysis using Review Manager 5 (<a href="./references#CD008312-bbs2-0063" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>).  </p> <p>Included studies were heterogeneous in terms of types of adherence‐enhancing interventions and methods used to measure and report adherence. This did not allow pooling of data. </p> </section> <section id="CD008312-sec-0033"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to analyse interventions and results in children and adults as separate subgroups throughout the review (results, analysis, discussion, implications for practice and research sections). </p> <p>We planned to conduct subgroup analyses of the primary outcomes, classifying the studies by interventions used, numbers of interventions, types of adherence measurement used, duration of follow‐up and epilepsy type, if the data permitted. </p> </section> <section id="CD008312-sec-0034"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to undertake sensitivity analyses to explore the influence of factors such as the quality of included studies on the results. </p> </section> <section id="CD008312-sec-0035"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a Summary of findings table using the browser‐based GRADEpro software, available to Cochrane review authors (<a href="./references#CD008312-bbs2-0046" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 1 June 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>) for the primary outcome (improved adherence to medication) and secondary outcomes (seizure frequency or seizure severity, self‐efficacy, and quality of life). For each outcome we summarised the following information. </p> <p> <ul id="CD008312-list-0007"> <li> <p>Risk in the intervention group and its 95% confidence interval based on the assumed risk in the comparison group and the relative effect of the intervention. </p> </li> <li> <p>Relative magnitude of effect and its 95% confidence interval.</p> </li> <li> <p>Numbers of participants and studies addressing these outcomes.</p> </li> <li> <p>A grade of the overall quality of the body of evidence for each outcome as described in <a href="#CD008312-sec-0028">Assessment of risk of bias in included studies</a>. </p> </li> <li> <p>Any relevant comments.</p> </li> </ul> </p> <p>We evaluated the overall certainty of evidence for outcomes identified as critical or important for clinical decision‐making using the GRADE approach (<a href="./references#CD008312-bbs2-0068" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). These outcomes included: effects on adherence (behavioural interventions), effects on adherence (educational interventions), effects on adherence (mixed interventions), seizure frequency and severity, self‐efficacy, and quality of life. The GRADE approach considers evidence from RCTs as high certainty, which may be downgraded based on consideration of any of five areas: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008312-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008312-sec-0036"></div> <section id="CD008312-sec-0037"> <h3 class="title">Description of studies</h3> <section id="CD008312-sec-0038"> <h4 class="title">Results of the search</h4> <p>The search of the databases resulted in 1040 'hits', from which we obtained 506 articles from MEDLINE, 317 from CENTRAL, 86 from PsycINFO, 25 from the Cochrane Epilepsy Group Specialised Register, 20 from ClinicalTrials.gov, 31 from CINAHL, and 14 from ICTRP. The search of CRS Web yielded 41 new hits (see <a href="#CD008312-fig-0001">Figure 1</a>). In previous versions of this review, searching Embase (Ovid 1980 to June 2012) contributed 2913 citations. However, the citations did not yield any new studies other than those identified in other databases. </p> <div class="figure" id="CD008312-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram (PRISMA Template)" data-id="CD008312-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram (PRISMA Template)</p> </div> </div> </div> <p>We screened titles and abstracts and excluded 301 duplicates and 702 irrelevant publications. The most common reason for exclusion at this stage was that studies did not perform any adherence‐enhancing intervention, or did not measure changes in adherence to medication, or both. The other common reason for exclusion was that the study population did not consist of participants with a clinical diagnosis of epilepsy; this was expected, as antiepileptic medications have many other clinical uses. The total number of citations after irrelevant and duplicate references were removed was 36. Two review authors reviewed these independently. We had categorised five records as relevant ongoing studies in a previous version of this review and included them in a later update. Three studies are possibly relevant ongoing studies (see <a href="./references#CD008312-sec-0090" title="">Characteristics of ongoing studies</a> table). </p> <p>We excluded nine studies (see <a href="./references#CD008312-sec-0089" title="">Characteristics of excluded studies</a> table). The reasons for exclusion are as follows: five because adherence as an outcome was not reported, two were not designed as RCTs, one was not clear if any people with epilepsy were included and, one where we were unable to obtain sufficient information to make a sound decision. We therefore included 20 studies in the current update, reporting data on 2832 participants. Thirteen of the 20 studies targeted adults with epilepsy (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>), one included participants of all ages (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>), one included participants ≥ 13 years (<a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>), one targeted caregivers of children with epilepsy (<a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>), one targeted adolescents and caregivers (<a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>), one recruited pediatric patients aged between 1 month to 15 years (<a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>), and two targeted families of children with epilepsy (<a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>; see <a href="./references#CD008312-sec-0088" title="">Characteristics of included studies</a> table). </p> </section> <section id="CD008312-sec-0039"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD008312-sec-0088" title="">Characteristics of included studies</a> table. </p> <p>Seven studies were conducted in the USA (<a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>; <a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>), three in China (<a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>), two in the UK (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), and Australia (<a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>), and one each in Canada (<a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>), India (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>), Iran (<a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>); Kenya (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>), the Netherlands (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>), and Thailand (<a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>). All but three studies compared treatment versus 'usual care' or 'no intervention': <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a> compared different formats of text messaging; <a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a> compared an educational intervention presented in different formats (oral form, oral and written, and by telephone contact only); and <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> compared educational versus behavioural interventions. Follow‐up times ranged from four weeks to one year. All included studies were RCTs, or described the randomisation procedure if 'RCT' was not specifically mentioned. </p> <section id="CD008312-sec-0040"> <h5 class="title">Type of interventions</h5> <p>Interventions that the studies examined could be grouped into behavioural, educational and mixed interventions. </p> <section id="CD008312-sec-0041"> <h6 class="title">Behavioural interventions</h6> <p> <ul id="CD008312-list-0008"> <li> <p>Reminder text messaging or application ('app') for the adolescent and caregiver (<a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>). </p> </li> <li> <p>Three, weekly face‐to‐face motivational interviewing sessions each lasting for 40 to 60 minutes. Patients then created a personal action plan by specifying where, when, how, and how often they would take medications and use a drug diary calendar to help them stick to their plans. Patients were encouraged to identify the barriers that might interfere with the implementation of their medication adherence plans and to specify how to overcome it (<a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>). </p> </li> <li> <p>Implementation intention interventions, which involved the completion of a simple worksheet by participants and linking of the intention of taking medication with a particular time, place and other routine activity (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>). For instance, the participant could write, "If it is 8 am and I am in the bathroom and have finished brushing my teeth, then I will take my first dose". </p> </li> <li> <p>Face‐to‐face introductory motivational interviews followed by four telephone‐based motivational interviews over 12 weeks. This intervention was provided by a specially‐trained nurse and was aimed at enhancing self‐management practices in the following areas: medication, information, seizures, safety and lifestyle (<a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>). </p> </li> </ul> </p> </section> <section id="CD008312-sec-0042"> <h6 class="title">Educational interventions</h6> <p> <ul id="CD008312-list-0009"> <li> <p>A multidisciplinary management programme including face‐to‐face interviews with an epileptologist, online consultations by epilepsy specialist nurses; and group education by the multidisciplinary team twice a year (<a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). </p> </li> <li> <p>One 120‐minute self‐management and lifestyle education session delivered face‐to‐face by a clinical nurse specialist in neurosciences (<a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>). </p> </li> <li> <p>Self‐management education for people with poorly controlled epilepsy (SMILE [UK]) is a group‐based education course with nine modules delivered for 16 hours over two consecutive days. The premise of the course was to communicate information and to encourage participants to share their own experiences with others. A workbook containing course content was given to participants (<a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>). </p> </li> <li> <p>An 8.52 min video animation on: diagnosis of epilepsy, aetiology of epilepsy, treatment of epilepsy, first aid seizure care, prognosis of epilepsy and safe activity for epilepsy (<a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>). </p> </li> <li> <p>Four face‐to‐face sessions and two telephone problem‐solving sessions over eight weeks. Session one addressed deficit in epilepsy knowledge. Sessions two through four aimed to teach families a problem‐solving approach for their identified antiepileptic drug‐adherence barriers (<a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>). </p> </li> <li> <p>One‐on‐one teaching in a structured format, covering aspects such as treatment modalities was administered by an epilepsy nurse in four sessions lasting at least 30 minutes; also pamphlets were provided, mostly with animations, to explain the different aspects of the disease (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>). </p> </li> <li> <p>A one‐day educational programme providing epilepsy‐related information such as types of seizures, causes of epilepsy, effects of epilepsy on child development, treatment of epilepsy, side effects of drugs and what to do during a seizure. A brochure detailing all of the topics discussed was given to each participant (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>). </p> </li> <li> <p>Medication education in the form of oral education and written materials, reinforced by monthly calls from the pharmacist over the next six months (<a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>). </p> </li> <li> <p>The first component of the intervention (session one) provided education on epilepsy treatment, antiepileptic drug adherence and the family’s specific epilepsy treatment regimen (i.e. dosing schedule). Sessions two through four aimed to teach families a problem‐solving approach for their identified antiepileptic drug adherence barriers (<a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>). </p> </li> <li> <p>An online epilepsy self‐management programme, Web Epilepsy Awareness, Support, and Education (WebEase), that assists people with taking medication, managing stress and improving sleep quality (<a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>). </p> </li> <li> <p>A two‐day Seizures and Epilepsy Education programme designed to provide medical education and psychosocial therapy to participants and families (<a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>). </p> </li> <li> <p>Three groups were given oral information about the name of the drug; its colour, shape and strength; the therapeutic effect; and dosage, precautions and possible unwanted effects; the same information supplemented by its presentation in written form; and the same information by telephone contact only (<a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>). </p> </li> <li> <p>Two mothers' discussion group meetings, each lasting 1.5 hours. The aim of these meetings was to provide mothers with information that would enable them to know what they should do for their children and why, and would allow them to increase their sense of responsibility while making their commitment (<a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>). </p> </li> </ul> </p> </section> <section id="CD008312-sec-0043"> <h6 class="title">Mixed interventions</h6> <p> <ul id="CD008312-list-0010"> <li> <p>The multicomponent self‐management intervention consisted of five weekly group sessions of two hours each, followed by a two‐hour booster session after three weeks. All group sessions consisted of two components: education and practicing goal‐setting skills (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>). </p> </li> <li> <p>Medication education (see description above) was combined with a behavioural intervention: a modified medication schedule, which was presented in the form of a table that illustrated the daily medication therapy of participants with pictures of antiepileptic drugs, and providing them with cues to take their medication (<a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>). </p> </li> <li> <p>A programme with four components: (1) intensive education, (2) consultation services to ensure that clinical providers and telephone support were available for participants at any time, (3) reminders provided by keeping a simple record with specifically designed cards, and (4) repeated participant reminders about medical adherence sent every month (<a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>). </p> </li> <li> <p>Patient counselling on the goals of antiepileptic drugs and the importance of sufficient adherence and intensive reminders: diary of medication use and seizures, Dosett medication container (pill organiser), and prescription refill and appointment‐keeping reminders (<a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>). </p> </li> </ul> </p> </section> </section> <section id="CD008312-sec-0044"> <h5 class="title">Adherence assessment and reporting</h5> <p>Studies measured adherence to antiepileptic drugs both directly and indirectly. Six studies used serum or plasma concentration of the antiepileptic drug (<a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>; <a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>). Indirect measurement techniques included use of the Medication Event Monitoring System (MEMS), an electronic monitoring cap that recorded the number and timing of bottle openings (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>); assessment of participant‐reported adherence using the Antiretroviral General Adherence Scale (AGAS; <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>), Epilepsy Self‐Management Scale (<a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), or the Medication Adherence Scale (MAS, MARS or Morisky MAS; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>); and tracking of prescription refill frequency and appointment keeping (<a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>). </p> <p>Adherence was reported as mean score, percentage change in adherence score from baseline to post‐intervention, percentage of doses taken, percentage of days correct doses were taken, percentage of doses taken on schedule, percentage of mean change from baseline to post‐intervention and percentage of change from the initial level towards the mean of the accepted therapeutic range (see Summary of results for each included study, <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </section> </section> <section id="CD008312-sec-0045"> <h4 class="title">Excluded studies</h4> <p>See the <a href="./references#CD008312-sec-0089" title="">Characteristics of excluded studies</a> table. </p> <p>We defined a list of the most common characteristics for the exclusion criteria.</p> <p> <ul id="CD008312-list-0011"> <li> <p>Inappropriateness of the study design: not a RCT or no randomisation procedure performed, or both </p> </li> <li> <p>Adherence as an outcome is not reported or no adherence‐enhancing intervention, or both </p> </li> <li> <p>Not an original publication</p> </li> <li> <p>The study was not performed in the field of epilepsy</p> </li> </ul> </p> </section> </section> <section id="CD008312-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>We applied the full version of Cochrane’s tool for assessing risk of bias (<a href="./references#CD008312-bbs2-0049" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.">Higgins 2017</a>). Descriptions by domain are provided below (see 'Risk of bias' summary for each included study, <a href="#CD008312-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD008312-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008312-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD008312-sec-0047"> <h4 class="title">Random sequence generation (selection bias)</h4> <p>Seven studies used computer‐generated randomisation, which we considered to be an adequate randomisation procedure (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). Three studies reported the use of block randomisation (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>). One study used stratified block randomisation with type of phone (<a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>). Another study (<a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>), stated that they used a simple randomisation method but did not describe it further. One study used the toss of a coin (<a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>). The risk of bias for random sequence generation was high in two studies ‐ one study used day of the week (<a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>) and one study reported that random allocation to groups was used; however, if a participant was unable to attend the intervention face‐to‐face session, they were placed into the control group (<a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>). Data on the method of randomisation were missing from the other study reports, so we cannot properly judge the adequacy of randomisation. </p> </section> <section id="CD008312-sec-0048"> <h4 class="title">Allocation</h4> <p>Only one study reported that the randomisation scheme was distributed to the researcher in sealed envelopes during the first visit, prior to baseline assessment (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>). None of the remaining 19 studies properly reported this domain, thus we cannot evaluate it. </p> <p>Sixteen studies provided comparative baseline information on the intervention and control groups (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>; <a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>, <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a> and <a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a> provided demographic characteristics for the whole study sample but did not present the characteristics of each group. In <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a> the authors provided the characteristics for the two groups and stated that the statistical comparison was not conducted owing to small sample sizes. Ten studies provided baseline adherence levels for both groups ( <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>; <a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). </p> </section> <section id="CD008312-sec-0049"> <h4 class="title">Blinding</h4> <p>None of the studies reported blinding of participants to the intervention they were receiving, as it was not possible in this particular setting. Only five studies reported blinding of healthcare providers or outcome assessors or both and we judged the risk of performance bias as low. <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> reported that researchers who completed follow‐up assessments and the patients ’ healthcare providers were blind, staff organising the courses were not involved in data collection and not blind, and the statistician remained blind until the end of the analysis. Laboratory technicians determining drug levels in the blood assays were blinded to randomisation in <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>, although the blinding procedure is incomplete and we therefore judged the study to have a high risk of bias. <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a> reported that study designers, local physicians and the data analyst were blinded to the intervention. <a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a> blinded the neurologist and clinic and pharmacy staff to group participation. <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a> blinded physicians treating study participants. Although blinding of healthcare providers should avoid systematic differences in the care provided (performance bias), this approach is vulnerable to disclosure by participants. In all studies it was unclear whether blinding of outcome assessors was maintained, and we therefore cannot determine the risk of detection bias. </p> </section> <section id="CD008312-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>Thirteen studies reported losses to follow‐up (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). However, it was apparent that participants lost to follow‐up were excluded from the analysis in only six studies (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>). Three studies reported using intention‐to‐treat analysis (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>). In 7 studies we judged risk of attrition bias as low because missing outcome data were balanced in numbers across groups with similar reasons for missing data. Missing outcome data detected in <a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a> and <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a> were likely to be related to true outcome, and to cause high risk of bias. The number of participants lost to follow‐up ranged from 2 to 157. </p> </section> <section id="CD008312-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Selective outcome reporting bias could occur, for instance, if seizure frequency was measured and analysed but was not reported in the study results. The study protocol or details were available only for four studies (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), and all outcomes reported in the protocol were reported either in the same paper or somewhere else. For studies with no protocols we cannot confirm or exclude this type of bias in the other seven studies as we did not contact study authors. Five studies (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>), published all expected outcomes. </p> </section> <section id="CD008312-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>Nine studies (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a>; <a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>), reported insufficient information to judge whether or not other risks of bias might have been introduced. Four studies discussed possible threats to validity:<a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a> argued that self‐reported responses might be affected by social desirability biases, including the tendency to overemphasise behaviour in favour of the desired outcomes; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a> reported many statistically non‐significant results; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a> reported that improved adherence in both groups could be explained by the sharing of knowledge between groups and participants who did not provide blood samples to assess AED drug levels held significantly more traditional religious and cultural beliefs; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a> discussed the impact of recall bias on the study findings. Only five studies (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), performed appropriate sample size calculations. </p> <p>One study met all seven quality criteria (<a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), one study met five criteria (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>), three studies (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>;<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>), met four quality criteria, four studies (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>), met three quality criteria, three studies (<a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>), met two quality criteria for risks of bias, and four studies met one quality criteria (<a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>; <a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>; <a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>; <a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>). </p> </section> </section> <section id="CD008312-sec-0053"> <h3 class="title" id="CD008312-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD008312-tbl-0001"><b>Summary of findings 1</b> Summary of findings table</a> </p> <p>The effects of interventions on identified outcomes can be found in <a href="./full#CD008312-tbl-0001">summary of findings Table 1</a>, and the results by study are described in <a href="./full#CD008312-tbl-0002">Table 1</a>. </p> <section id="CD008312-sec-0054"> <h4 class="title">Effects on adherence</h4> <section id="CD008312-sec-0055"> <h5 class="title">Behavioural interventions</h5> <p>Four studies examined behavioural interventions.</p> <p><a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>: the implementation intention intervention (69 participants) showed improved adherence relative to control. The percentage of doses taken in the intervention group was 93.4% (standard deviation (SD) 12.3%) versus 79.1% (SD 28.1%) in the control group (P = 0.01). The percentage of days on which correct doses were taken in the intervention group was 88.7% (SD 15.1%), versus 65.3% (SD 35.6%) in the control group (P = 0.01). The percentage of doses taken on schedule in the intervention group was 78.8% (SD 23.5%), versus 55.3% (SD 34.8%) in the control group (P = 0.001). The overall adherence scores were generated by standardising and then averaging the three percentage measures. The mean overall adherence score in the intervention group was 0.35 (SD 0.55), versus 0.40 (SD 1.15) in the control group (P &lt; 0.01). </p> <p><a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>: use of motivational interviewing to enhance self‐management practices had no effect on adherence (20 participants). The percentage of doses taken in the intervention group was 81.29% (SD 13.48%) versus 82.19% (SD 21.76%) in the control group (P = 0.912). The percentage of doses taken on schedule in the intervention group was 53.27% (SD 17.74%) versus 66.01% (SD 29.61%) in the control group (P = 0.258). The mean AGAS score in the intervention group was 4.28 (SD 0.74) versus 4.46 (SD 0.58) in the control group (P = 0.523). </p> <p><a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a>: text messaging and phone applications targeting teenagers with and without caregivers resulted in minimal adherence improvements due to high levels of baseline adherence. A trend indicated that parental involvement decreased adherence and text messaging improved adherence compared to applications. </p> <p><a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>: the motivational interviewing group (138 participants) reported significantly higher medication adherence compared with the control group (137 participants) at three‐month (β = 4.6; P = 0.001) and six‐month (β = 1.73; P = 0.001) follow‐up. The odds ratios (OR) of serum level increased by 1.35 in participants in the intervention group (OR 1.35, 95% CI 1.07 to 1.71; P = 0.03) compared with those in the active comparator group at three months' follow‐up. </p> </section> <section id="CD008312-sec-0056"> <h5 class="title">Educational interventions</h5> <p>Thirteen studies assessed the added value of educational interventions.</p> <p><a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>: in the epilepsy health education group, the pretest mean adherence score was 6.58, whereas the post‐test mean score was 7.53 (P = 0.001). The mean adherence scores for the control group's pretest and post‐test were 6.46 and 6.58 respectively (P = 0.224). </p> <p><a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>: use of the online epilepsy self‐management programme WebEase was found to be an effective means of enhancing adherence (148 participants). The mean adherence score after 12 weeks was 7.33 in the intervention group (SD 1.833), versus 6.90 (SD 2.33) in the control group (P = 0.049), with a mean difference of 0.43 (95% CI ‐0.24 to 1.10). </p> <p><a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a>: the difference in mean change adherence scores between control and intervention was −0.388 (95% CI −1.27 to 0.493; P = 0.376). </p> <p><a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>: the intervention group showed a significant and sustained increase in blood serum concentrations of antiepileptic medication from baseline to four‐month follow‐up (a mean increase of 70%). Over the same period, the control group showed a mean decline in blood serum levels of 18% (P &lt; 0.05). </p> <p><a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>: one year after an educational intervention was provided, there was no significant difference in adherence to antiepileptic drugs based on detectable drug levels (OR 1.46, 95% CI 0.74 to 2.90; P = 0.28) or by self‐reports (OR 1.00, 95% CI 0.71 to 1.40; P = 1.00) between the intervention and nonintervention groups. </p> <p><a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a>: in the group of children and their caregivers who received educational interventions, the mean percentage change in adherence from baseline to post‐intervention was 31.5 (SD 52.9), versus 9.3 (SD 8.7) in the no‐intervention group. The authors reported that the statistical comparison was not conducted, owing to small sample sizes. </p> <p><a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a>: adherence scores after session 4 were 15.3 in the intervention group versus 9.7 in the nonintervention group (P value &lt; 0.05). There were no significant group differences on antiepileptic drug adherence during the three‐month follow‐up period. </p> <p><a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a> reported that whether information was given in oral form alone or both orally and in written form, it produced no significant rise or fall in the mean serum level of prescribed antiepileptic medication. </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>: at 12 months, the medication adherence score median for the intervention group was 47.8 (interquartile range (IQR) 45.6 to 48.9; range 27.8 to 50.0) versus 47.8 (IQR 45.6 to 48.9; range 35.6 to 50.0) in the nonintervention group (P = 0.964). </p> <p><a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>: the proportion of participants with improved adherence after three months was higher in the intervention group (54 (42.9%)) versus the control group (141 (5.9%); P value &lt; 0.001). </p> <p><a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a> reported that the mean adherence score derived from serum level for children of parents who received the intervention was 2.9 versus 2.2 in the control group (P = 0.015). </p> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> reported that adherence improved in both the medication education group (62.3%) and the medication education with behavioural intervention group (64.3%); P value = 0.827. </p> <p><a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a>: at 12‐month follow‐up compared with baseline, there was an increase in number of participants with moderate to high antiepileptic drug adherence was observed in the intervention group (65 (60.9%) versus 71 (77.2%); P = 0.006) and in the control group (55 (59.8%) versus 63 (68.5%); P = 0.096). </p> </section> <section id="CD008312-sec-0057"> <h5 class="title">Mixed interventions</h5> <p>Four studies focused on mixed interventions, with one study (<a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>), comparing an educational intervention plus a behavioural component to a single educational intervention (described in the 'Educational intervention' section). </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>: at six months the adherence rates were 63.7% and 75.9% and the adherence scores were 23.7 (SD 1.3) and 23.9 (SD 0.9) for the non‐intervention and the intervention groups respectively; the difference was not statistically significant. </p> <p><a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a> reported no statistically significant differences at baseline between the numbers of participants in intervention and non‐intervention groups who rated their adherence as excellent or very good (12.6% versus 9.1% respectively; P = 0.579). One year after the intervention was provided, 77.6% of intervention group members rated their adherence as excellent or very good, versus 9.6% in the non‐intervention group (P &lt; 0.001). </p> <p><a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>: use of patient prompts, such as mailed reminders for prescription refills and appointments, together with a counselling leaflet, produced positive effects on adherence. At follow‐up, mean serum levels of phenytoin, carbamazepine and sodium valproate were higher in the intervention group than in the control group, and this was accompanied by a greater shift from subtherapeutic to therapeutic plasma levels in the intervention group than in the control group (P &lt; 0.005). The high serum level can be explained by participants taking more medication rather than higher doses, as no significant changes in antiepileptic drug dosages were reported within treatment groups. The proportion of compliant participants, as judged by prescription refill frequencies, was higher in the intervention group than in the control group (88% versus 50%; P &gt; 0.01). There was no difference between the intervention and control groups for appointment‐keeping (59% versus 65%; P &gt; 0.5). </p> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>: after intervention adherence increased greatly in all participants and the number who missed antiepileptic drugs decreased to 45.0% from 64.3% (P = 0.988). Adherence improved in 62.3% of education group versus 64.3% of education/behavioural group participants (P = 0.827). </p> </section> </section> <section id="CD008312-sec-0058"> <h4 class="title">Effects on seizure frequency or seizure severity</h4> <p>Eleven studies described seizure frequency or seizure severity or both, with four of them (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>; <a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a>), presenting improved adherence and decreased seizure frequency in the intervention groups. </p> <p><a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a> reported a higher proportion of participants with decreased seizure frequency in the intervention compared to the control group (34.1% versus 18.6%; P = 0.043 ) six months after the intervention. The rest of the participants either had increased seizure frequency (12.3% versus 14.3%; P = 0.811), or unchanged (53.6% versus 67.1%; P = 0.099). </p> <p><a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a> reported the mean seizure occurrences between the control (12.71, SD 24.55) and intervention (6.76, SD 13.40) groups. </p> <p><a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a> reported that seizure frequencies did not change significantly from baseline to follow‐up in either intervention or control groups. </p> <p><a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a> reported no difference in seizure frequency between the groups (P = 0.58). </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a> reported no difference in seizure severity measured using the National Hospital Seizure Severity Scale (NHS3) between intervention (6.2 (SD 7.3)) and control (8.7 (SD 10.0)). </p> <p><a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a> reported that before the intervention, baseline numbers of participants with more than a 50% seizure reduction were similar in the two groups (50.9% versus 45.8%; P = 0.337). After the intervention, the proportion of participants with more than a 50% seizure reduction rose to 79.8% in the intervention group, compared with 61.0% in the non‐intervention group (P &lt; 0.05). </p> <p><a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a> compared the number of seizures between intervention and control groups at follow‐up and found no statistically significant differences (median 2.5 versus 3.5; P &gt; 0.5). The reduction in seizure frequency from baseline was more observed for the intervention group (median from 6 to 2.5; P &lt; 0.01) versus the control group (median from 4 to 3.5; P &gt; 0.1). </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> reported a difference between the two study arms in a number of participants with ≥1 seizure per month as − 0.02 (95% CI −0.63 to 0.58; P = 0.939). </p> <p><a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a> reported a higher proportion of participants with improved severity of seizure in the intervention group 47 (37.3%) than control group 22 (25.0%) (P = 0.14). </p> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> reported no difference in seizure control between the medication education group and the behavioural intervention group (64.2% versus 64.3%; P = 0.988). </p> <p><a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a> reported an increase in the proportion of participants with a low seizure frequency in both the intervention group (70 (76.1%) versus 41 (44.6%); P= 0.001) and the control group (74 (80.4%) versus 50 (54.3%); P = 0.001) however, the difference between the two groups, is not significant (80.5% versus 76.1%; P = 0.475). </p> </section> <section id="CD008312-sec-0059"> <h4 class="title">Effects on self‐efficacy</h4> <p>Five studies (<a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a>; <a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a>; <a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>), reported self‐efficacy effects and one study reported self‐mastery (<a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>). Four studies used the Epilepsy Self‐Efficacy Scale (ESES), which measures different aspects of efficacy in people with epilepsy, rating the items on an 11‐point (Likert) rating scale covering personal levels of confidence regarding the ability to manage epilepsy. One study (<a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a>), presented self‐efficacy using the Sherer’s Self‐Efficacy Scale. </p> <p><a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a> used continuous variables to represent a total score and the assessment was administered by a specialised epilepsy nurse. The intervention, however, did not improve the overall self‐efficacy score in participants with epilepsy. </p> <p><a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a> reports a positive effect of self‐efficacy on understanding ability for self‐management practices. Much higher levels of self‐efficacy (mean intervention group 8.63 (SD 1.23) compared to the mean in the control group of 7.51 (SD 1.53)) were shown in the intervention group, resulting in better seizure management and epilepsy knowledge (T = 1.757, P = 0.097). </p> <p><a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a> showed higher levels of self‐efficacy at post‐intervention measurement in participants receiving the intervention compared to the control group. The trend testing was significant, with a post‐intervention mean of 188.02 (SD 32.88) versus 171.17 (SD 40.21) in the intervention group versus the control group respectively (F = 6.49, P = 0.0130). </p> <p><a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a> reported general and social self‐efficacy using Sherer's Self‐Efficacy scale. Both mean scores, however, were higher in the control group compared to the intervention group at pre‐assessment and at four months' follow‐up. </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a> reported no significant difference in self‐efficacy between the intervention and control (263.2 (SD 26.3) versus 252.3 (SD 32.8)). </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> reported that self‐mastery changed little at the 12‐month follow‐up with no statistically significant difference between study arms. </p> </section> <section id="CD008312-sec-0060"> <h4 class="title">Effects on quality of life</h4> <p>Seven studies reported quality of life as an outcome.</p> <p><a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a> measured quality of life using the SF‐12 (Short‐Form 12 question) health survey. The difference in mean change scores between control and intervention for physical health quality‐of‐life score was −4.60 (95% CI −10.6 to 1.42; P = 0.129) and for the mental health quality‐of‐life score it was −1.97 (95% CI −7.67 to 3.74; P value = 0.487). </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a> reported that the difference in total Quality of Life in Epilepsy Scale (QOLIE‐31P) scores between the intervention and control groups was not significant but three subscales ‘Emotional well‐being’ (P = 0.01), ‘Social functioning’ (P = 0.001), and ‘Distress’ (P = 0.01) had a significantly better result in the intervention group. </p> <p><a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a> measured the impact on quality of life using a feasibility and acceptability questionnaire. The questionnaire included one item, “Treatment helped improve my child’s quality of life” rated on a 7‐point Likert scale by four families who received the intervention. A mean benefit of 6.75 (SD 0.6) was reported. </p> <p><a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a> assessed quality of life using the QOLIE‐31. At six months, no significant changes from baseline in any domain were evident in the control group (from 52.85 (SD 17.98) to 52.25 (SD 17.21)). In participants receiving intervention, the mean changes from baseline to six months after intervention were significant (from 53.75 (SD 19.52) to 62.67 (SD 14.51). </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> measured quality of life as main outcome using Quality of Life in Epilepsy‐31 with added Patient‐specific weightings (QOLIE‐31‐P). The analysis did not detect any difference at 12‐month follow‐up between the mean scores for intervention (67.4,SD 13.5) and nonintervention (69.5, SD 14.8); P value = 0.564. </p> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> presented the overall quality of life using the Quality of Life in Epilepsy Scale‐10 (QOLIE‐10), with each of the 10 items rated on a five‐point scale. The difference in scores between the two groups was not clear (P = 0.9475). </p> <p><a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a> assessed the quality of life using the Quality of life in Epilepsy‐31(QOLIE‐31). After 12 months, the intervention group showed improvements in five of the seven subscales in QOLIE‐31, while the control group showed improvements in only in three aspects. </p> </section> <section id="CD008312-sec-0061"> <h4 class="title">Effects on side effects, serious adverse events</h4> <p>Two studies examined the effects of interventions on treatment side effects and serious adverse events. </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>: at six months, there was a significant difference on the side‐effect scale (SIDAED) between intervention 19.1 (SD 15.3) and control 25.5 (SD 19.1; P value = 0.04). </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> reported insignificant differences in median adverse effects of medications between intervention and control (7 (range 2 to 10) versus 8 (range 2 to 10); P = 0.151). </p> </section> <section id="CD008312-sec-0062"> <h4 class="title">Costs and cost effectiveness</h4> <p>Two studies (<a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>), measured costs and estimated cost effectiveness of the intervention (the results are reported in the secondary references). </p> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>: the self‐management intervention for adults with epilepsy (ZMILE study) intervention costs were EUR 648 at 12 months' follow‐up. For the control group the costs were EUR 95, which were mainly protocol‐driven costs attributable to the MEMS bottle. At 12 months, total costs were EUR 9314 for the intervention group and EUR 8189 for the control group. The intervention resulted in an incremental cost‐effectiveness ratio of EUR 88 per percentage of adherence increase at six months. When looking at the quality adjusted life years (QALYs; Dutch tariff), an incremental cost‐utility ratio of EUR 15,144 per QALY was gained at 12‐month follow‐up. All costs were indexed for the year 2015. </p> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>: a complete course of the self‐management education for adults with poorly controlled epilepsy (SMILE (UK)), with four sessions, was estimated to be GBP 224.00. At 12 months follow up, health and social care costs and total societal costs were GBP 3453 and GBP 30,732 for the SMILE (UK) intervention group compared to GBP 4608 and GBP 30,675 for treatment as usual group, respectively. The associated incremental cost‐effectiveness ratio from a health and social care perspective is GBP 5548 per one extra QALY. Costs are reported at 2014 to 2015 prices. </p> <p><a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a> argues that the intervention will be more cost‐effective, mainly because it is an online product that will save working hours and require less administration in comparison with usual care. However they did not present any further information on cost effectiveness. No further reports described costs associated with adherence‐modifying interventions. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008312-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008312-sec-0063"></div> <section id="CD008312-sec-0064"> <h3 class="title" id="CD008312-sec-0064">Summary of main results</h3> <p>We identified 20 studies examining the effects on adherence to antiepileptic drugs using different interventions. Among these, four studies used behavioural interventions, 13 studies used educational interventions and four studies used mixed interventions. One study (<a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a>), compared an educational intervention plus a behavioural component to a single educational intervention, and we have therefore presented the study results in both the educational intervention and in the mixed intervention categories. </p> <p>The aim of this review was to assess the effectiveness of interventions aimed at improving adherence to antiepileptic medication. Education and counselling of people with epilepsy showed mixed success. Behavioural interventions, such as the use of intensive reminders and implementation intention interventions, demonstrated more favourable effects on adherence. Mixed interventions were shown to improve adherence in the intervention groups compared to the control groups. </p> <p>The impact of these interventions on secondary outcomes such as seizure frequency, self‐efficacy, and quality of life were reported by a limited number of studies with mixed results and no clear pattern across types of intervention.. </p> <p>Due to very limited number of studies and the small sample sizes, further studies are needed to confirm the initial indications that adherence to antiepileptic drugs can be improved by these means. </p> </section> <section id="CD008312-sec-0065"> <h3 class="title" id="CD008312-sec-0065">Overall completeness and applicability of evidence</h3> <p>Applicability of the findings to everyday practice is uncertain for many reasons. Firstly, translation of education, counselling and motivation from the study setting to everyday practice is not necessarily feasible. Secondly, improving medication adherence will not necessarily translate into clinical benefits for the patient (<a href="./references#CD008312-bbs2-0059" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>; <a href="./references#CD008312-bbs2-0064" title="RoterDL , HallJA , MeriscaR , NordstromB , CretinD , SvarstadB . Effectiveness of interventions to improve patient compliance: a meta-analysis. Medical Care1998;36(8):1138-61. [DOI: 10.1097/00005650-199808000-00004] [PMID: 9708588]">Roter 1998</a>). The effects of adherence‐enhancing interventions must therefore be judged by their clinical outcomes. Outcomes such as reduced seizure frequency, quality of life and side effects were not always reported by the included studies. Out of 11 studies that reported seizure frequency, four showed a statistically significant decrease in seizure frequency when adherence was also improved. Thirdly, the value of adherence research to clinical practice is enriched by studying the relationship between adherence and factors known to influence adherence (<a href="./references#CD008312-bbs2-0039" title="DiMatteoMR . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care2004;42(3):200-9. [DOI: 10.1097/01.mlr.0000114908.90348.f9] [PMID: 15076819]">DiMatteo 2004</a>). Only two studies examined the relationship between adherence and patient‐related factors (<a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>), and found no statistically significant relationship between them. Fourthly, short‐term follow‐up makes it difficult to ascertain whether interventions with promising adherence‐improving effects can maintain their effects over time. Finally, adherence‐enhancing interventions require utilisation of healthcare resources, meaning that cost‐effectiveness information is required for informed decision‐making about their implementation. Two of the identified studies discussed the cost implications of these interventions. </p> </section> <section id="CD008312-sec-0066"> <h3 class="title" id="CD008312-sec-0066">Quality of the evidence</h3> <p>Twenty studies met our inclusion criteria. Insufficient reporting of what happened in these studies has hindered our ability to ascertain all risks of bias. For instance, we were unable to establish for all the studies the adequacy of the generation of the allocation sequence and of allocation concealment, and differences between baseline characteristics of the groups that were compared. Information on calculation of the statistical power of the sample size was provided in only five studies (<a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a>; <a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a>). Inadequate sample size could increase the likelihood of a type II error, and other biases. </p> <p>In adherence‐enhancing intervention studies, the validity and reliability of adherence measurement and reporting are central. Among the different measures of adherence, no single intervention can be regarded as a gold standard, and use of multiple measures of adherence is recommended (<a href="./references#CD008312-bbs2-0039" title="DiMatteoMR . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care2004;42(3):200-9. [DOI: 10.1097/01.mlr.0000114908.90348.f9] [PMID: 15076819]">DiMatteo 2004</a>; <a href="./references#CD008312-bbs2-0040" title="EatockJ , BakerGA . Managing patient adherence and quality of life in epilepsy. Neuropsychiatric Disease and Treatment2007;3(1):117-31. [PMID: 19300542]">Eatock 2007</a>; <a href="./references#CD008312-bbs2-0058" title="NicholMB , VenturiniF , SungJC . A critical evaluation of the methodology of the literature on medication compliance. Annals of Pharmacotherapy1999;33(5):531-40. [DOI: 10.1345/aph.18233] [PMID: 10369613]">Nichol 1999</a>; <a href="./references#CD008312-bbs2-0060" title="PaschalAM , HawleySR , St RomainT , AblahE . Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia2008;49(7):1115-22. [DOI: 10.1111/j.1528-1167.2008.01645.x] [PMID: 18479395]">Paschal 2008</a>; <a href="./references#CD008312-bbs2-0070" title="VermeireE , HearnshawH , Van RoyenP , DenekensJ . Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics2001;26(5):331-42. [DOI: 10.1046/j.1365-2710.2001.00363.x] [PMID: 11679023]">Vermeire 2001</a>). Only four studies used more than one adherence measure (<a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a>; <a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a>; <a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a>; <a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a>). </p> <p>We examined the overall certainty of evidence for selected outcomes. This was high for effects on adherence with mixed interventions and quality of life; moderate for effects on adherence with behavioural interventions, effects on adherence with educational interventions, and seizure frequency and severity; and low for self‐efficacy. </p> </section> <section id="CD008312-sec-0067"> <h3 class="title" id="CD008312-sec-0067">Potential biases in the review process</h3> <p>We did not contact authors of excluded studies to enquire whether adherence was measured but not reported, and therefore cannot exclude outcome reporting bias from our review (<a href="./references#CD008312-bbs2-0051" title="KirkhamJJ , DwanKM , AltmanDG , GambleC , DoddS , SmythR , et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ2010;340:c365. [DOI: 10.1136/bmj.c365] [PMID: 20156912]">Kirkham 2010</a>). </p> </section> <section id="CD008312-sec-0068"> <h3 class="title" id="CD008312-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>One review (<a href="./references#CD008312-bbs2-0036" title="da Mota GomesM , NavarroT , KeepanasserilA , JefferyR , HaynesRB . Increasing adherence to treatment in epilepsy: what do the strongest trials show?Acta Neurologica Scandinavica2017;135(3):266–72. [DOI: 10.1111/ane.12668] [PMID: 27573252]">da Mota Gomes 2017</a>), of RCTs of interventions to enhance adherence with antiepileptic drugs, which also measured clinical outcomes with at least 80% follow‐up of participants for at least six months, identified four studies and concluded that evidence is limited concerning enhancement of adherence among people with epilepsy. Several systematic reviews have examined the issues of adherence‐enhancing interventions in general (<a href="./references#CD008312-bbs2-0059" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>; <a href="./references#CD008312-bbs2-0061" title="PetersonAM , TakiyaL , FinleyR . Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health-System Pharmacy2003;60(7):657-65. [DOI: 10.1093/ajhp/60.7.657] [PMID: 12701547]">Peterson 2003</a>; <a href="./references#CD008312-bbs2-0064" title="RoterDL , HallJA , MeriscaR , NordstromB , CretinD , SvarstadB . Effectiveness of interventions to improve patient compliance: a meta-analysis. Medical Care1998;36(8):1138-61. [DOI: 10.1097/00005650-199808000-00004] [PMID: 9708588]">Roter 1998</a>); others have focused on adherence in older people (<a href="./references#CD008312-bbs2-0048" title="HigginsN , ReganC . A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age and Ageing2004;33(3):224-9. [DOI: 10.1093/ageing/afh072] [PMID: 15082425]">Higgins 2004</a>), adherence to lipid‐lowering medication (<a href="./references#CD008312-bbs2-0066" title="SchedlbauerA , DaviesP , FaheyT . Interventions to improve adherence to lipid lowering medication. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD004371. [DOI: 10.1002/14651858.CD004371.pub3]">Schedlbauer 2010</a>), to type 2 diabetes treatment recommendations (<a href="./references#CD008312-bbs2-0071" title="VermeireEI , WensJ , Van RoyenP , BiotY , HearnshawH , LindenmeyerA . Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews2005, Issue 2. Art. No: CD003638. [DOI: 10.1002/14651858.CD003638.pub2]">Vermeire 2005</a>), and to antihypertensive medication (<a href="./references#CD008312-bbs2-0067" title="SchroederK , FaheyT , EbrahimS . Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database of Systematic Reviews2004, Issue 3. Art. No: CD004804. [DOI: 10.1002/14651858.CD004804]">Schroeder 2004</a>). Remarks on internal and external validity of the adherence literature in previous reviews are concordant with those in our review. Reviews looking at the methodological rigour of the literature on patient compliance with medication have similarly emphasised the importance of reliability and validity of adherence measurement (<a href="./references#CD008312-bbs2-0035" title="CramerJA , RoyA , BurrellA , Fairchild CJ, FuldeoreMJ , OllendorfDA , et al. Medication compliance and persistence: terminology and definitions. Value in Health2008;11(1):44-7. [DOI: 10.1111/j.1524-4733.2007.00213.x] [PMID: 18237359]">Cramer 2008</a>; <a href="./references#CD008312-bbs2-0039" title="DiMatteoMR . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care2004;42(3):200-9. [DOI: 10.1097/01.mlr.0000114908.90348.f9] [PMID: 15076819]">DiMatteo 2004</a>; <a href="./references#CD008312-bbs2-0058" title="NicholMB , VenturiniF , SungJC . A critical evaluation of the methodology of the literature on medication compliance. Annals of Pharmacotherapy1999;33(5):531-40. [DOI: 10.1345/aph.18233] [PMID: 10369613]">Nichol 1999</a>; <a href="./references#CD008312-bbs2-0070" title="VermeireE , HearnshawH , Van RoyenP , DenekensJ . Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics2001;26(5):331-42. [DOI: 10.1046/j.1365-2710.2001.00363.x] [PMID: 11679023]">Vermeire 2001</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008312-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/urn:x-wiley:14651858:media:CD008312:CD008312-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram (PRISMA Template)" data-id="CD008312-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_t/tCD008312-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram (PRISMA Template)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008312-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/urn:x-wiley:14651858:media:CD008312:CD008312-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008312-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_t/tCD008312-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/media/CDSR/CD008312/image_n/nCD008312-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008312-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults and children with epilepsy<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> adherence‐enhancing intervention<br/><b>Comparison:</b> no intervention or other intervention </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no intervention or other intervention</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with adherence‐enhancing intervention</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (behavioural interventions)</b><br/>Assessed with MEMS caps, self‐reported Antiretroviral General Adherence Scale (AGAS), the serum level and the Medication Adherence Report Scale (MARS)<br/>Follow‐up: range 1 month to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>391<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies showed significant improvement in adherence (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). 1 study showed minimal adherence improvements by the end of the follow‐up in combination with high levels of baseline adherence. Due to different interventions and assessment methods we are unable to draw further conclusions. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (educational interventions)</b><br/>Assessed with serum or plasma concentration, Medication Adherence Scale (MAS), MEMS, TrackCap and a 10‐item subscale from ‘Epilepsy Self‐management Scale’, the Morisky Medication Adherence Scale (MMAS‐8).<br/>Follow‐up: range 4 weeks to 13 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1938<br/>(13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 5 studies presented significant results of improved adherence. 1 study included families (the information on the total number of people is not specifically mentioned). Due to different interventions and assessment methods, we are unable to draw further conclusions (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on adherence (mixed interventions)</b><br/>Assessed with serum or plasma concentration, Medication Adherence Scale (MAS), MEMS, and Medication Adherence Scale (MARS‐5)<br/>Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>612<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>b</sup><br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 studies reported significant improvement in adherence. Due to heterogeneity of interventions and assessment methods, we are unable to draw further conclusions (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Seizure frequency and/or seizure severity</b> </p> <p>Assessed by National Hospital Seizure Severity Scale (NHS3), seizure diary and self‐reporting<br/>Follow‐up: range 4 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2147<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased seizure frequency and/or seizure severity related to improved adherence to AEDs was described in 4 out of 11studies presenting this secondary outcome. 2 studies reported improvement, however, no significant difference between 2 groups was reported or showed any changes. </p> <p>In 1 study, the intervention was associated with a stronger impact on self‐efficacy and seizure management (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐efficacy</b><br/>Assessed with the Epilepsy Self‐Efficacy Scale (ESES), General Self‐Efficacy Scale (GSES) and Sherer's Self‐Efficacy Scale<br/>Follow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>453<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>a,c</sup><br/>Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study presented significantly important results supporting improvement in self‐efficacy skills. Other studies reporting positive effects as a result of an intervention with mixed reliability (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b><br/>Assessed with Quality of Life in Epilepsy Scale (QOLIE‐10, QOLIE‐31‐P) and </p> <p>health‐related quality</p> <p>of life (HRQOL)</p> <p>Follow‐up: range 4 months to 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable<br/>See comments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1027<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>a,b</sup><br/>Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study reported significant benefit in the intervention group. 3 studies showed that there were no statistically significant differences and another study failed to present results supporting the added value of an intervention. Another study tried to evaluate HRQoL and to discuss relationships with other related outcomes: patients with lower QoL values were reporting lower levels of general well being and satisfaction. (see Summary of results for each included study <a href="./full#CD008312-tbl-0002">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AED:</b> antiepileptic drug; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>MEMS:</b> Medication Event Monitoring System; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The certainty of the evidence of the studies measuring this outcome was downgraded due to the lack of precision or lack of consistency, or both.<br/><sup>b</sup>The majority of studies measuring this outcome were not at high risk of bias.<br/><sup>c</sup>The certainty of the evidence of the studies measuring this outcome was downgraded due to the lack directness. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008312-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of results for each included study</span></div> <tbody> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Behavioural interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0001" title="BrownI , SheeranP , ReuberM . Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy &amp; Behavior2009;16(4):634-9. [DOI: 10.1016/j.yebeh.2009.09.014] [PMID: 19864187]">Brown 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants completed a 14‐page packet of self‐report measures. Adherence was measured with MEMS cap. To assess the equivalence of control and intervention groups, and to identify factors that could moderate the impact of the intervention, a collection of self‐report measures was applied (methods such as a single‐item self‐estimate of the number of missed doses during the preceding month, BIPQ, TPB, MASQ, HADS, PRMQ, LSSS were administered at baseline and at follow‐up. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANOVA and Chi<sup>2</sup> test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention participants showed improved adherence relative to controls on all 3 outcomes: doses taken in total (93.4% vs 79.1%), days on which correct dose was taken (88.7% vs 65.3%), and doses taken on schedule (78.8% vs 55.3%); P &lt; 0.01 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0003" title="DiIorioC , ReisingerEL , YeagerKA , McCartyF . A telephone-based self-management program for people with epilepsy. Epilepsy &amp; Behavior2009;14(1):232-6. [DOI: 10.1016/j.yebeh.2008.10.016] [PMID: 19010447]">DiIorio 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using MEMS cap and self‐reported medication adherence via AGAS (at baseline and follow‐up assessment). The following scales were also used: ESMS (follow‐up assessment only), ESES, and knowledge about epilepsy measured by EKQ. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Independent t‐test used to compare treatment and control group on variables assessed at follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prescribed doses taken overall in the intervention group was 81.29% (SD 13.48) and doses taken on schedule 53.27% SD (17.74). The results for adherence and self‐efficacy were in the correct direction and statistically significant only at the 0.10 level, suggesting that the intervention may also improve confidence in self‐management </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0011" title="ModiAC , MannKA , UrsoL , PeughJ . Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy &amp; Behavior2016;63:46-9. [DOI: 10.1016/j.yebeh.2016.07.036] [PMID: 27565437]">Modi 2016a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MEMS TrackCap (Aardex Corporation). The cap contains a microchip to register the dates and times the bottle is opened and closed. </p> <p>For families using a pill box, adolescents were asked to use a The SimpleMed + to administer AED. When a compartment is opened a date/time stamp is sent wirelessly to a secure website, which was accessed by study staff. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hierarchical linear modelling (HLM)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The results are not reported clearly, but it appears that there were high levels of baseline adherence and minimal adherence improvements among all groups. Group 4 demonstrated lower overall adherence compared to all groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0013" title="PakpourAH , GholamiM , EsmaeiliR , NaghibiSA , UpdegraffJA , MolloyGJ , et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy &amp; Behavior2015;52(Pt A):133–42. [DOI: 10.1016/j.yebeh.2015.08.036] [PMID: 26414343]">Pakpour 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The primary outcomes were adherence to prescribed AEDs, assessed with serum level and the MARS. </p> <p>QoL and several psychosocial variables were also measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The linear mixed models (PROCMIXED) for continuous outcome variables.</p> <p>As serum level was a binary outcome, a logistic mixed model was conducted to assess the intervention effects on the serum level in patient groups between the two arms. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a progressive increase in average MARS in the intervention group, but no change was observed in the standard care group. Patients in the intervention group reported significantly higher medication adherence compared with those in the active comparator group at 3‐month (β = 4.6, p b 0.001) and 6‐month (β = 1.73, p b 0.001) follow‐up. </p> <p>The ORs of serum level were increased by 1.35 in participants in the intervention group (OR 1.35, 95% CI 1.07 to 1.71; P = 0.03) compared with those in the active comparator group at 3 months' follow‐up. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Educational interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0002" title="DashD , SebastianTM , AggarwalM , TripathiM . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy &amp; Behavior2015;44:213–17. [DOI: 10.1016/j.yebeh.2014.12.030] [PMID: 25768712]">Dash 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug adherence and self‐care were measured respectively using the modified MMAS and the ESES. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistical analysis was carried out using SPSS software (version 16 for Windows), a paired t‐test was applied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the intervention group, the pre‐test mean MMAS score was 6.58, whereas the post‐test mean MMAS score was 7.53; the difference was significant (P = 0.001). The mean MMAS scores for the control group's pre‐test and post‐test were 6.46 and 6.58 respectively, which were not significantly different (P = 0.224). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0004" title="DiIorioC ,  BampsY ,  WalkerER ,  EscofferyC . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy &amp; Behavior2011;22(3):469-74. [DOI: 10.1016/j.yebeh.2011.07.030] [PMID: 21889413]">Dilorio 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence was measured using the MAS 8‐item measurement of self‐reported medication‐taking behaviours; perceived stress was measured by PSS and the ESI‐R. </p> <p>PSQI, ESMS, ESES, EKP and QOLIE‐10 measurements were also assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeated ANOVA measures were conducted using SPSS version 18.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trends toward statistical significance were noted for medication adherence (P = 0.118), stress (P = 0.098), self‐management (P = 0.098), and knowledge (P = 0.077). Participants who completed WebEase modules (intervention group) reported an increase in self‐efficacy (P = 0.013), meaning that they were more positive about their ability to manage medication, stress, or sleep issues. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0005" title="EdwardKL , CookM , StephensonJ , GiandinotoJA . The impact of brief lifestyle self‑management education for the control of seizures. British Journal of Nursing2019;28(6):348-54. [DOI: 10.12968/bjon.2019.28.6.348] [PMID: 30925235]">Edward 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seizure frequency: seizure diary</p> <p>Psychological morbidity and HRQoL: SF‐12</p> <p>Subjective well‐being: SWLS</p> <p>Resilience: CD‐RISC</p> <p>Adherence: MMAS‐8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before and after scores were compared using repeated ANOVA measures. Analyses of covariances were conducted on each of the outcomes, measured at time point 2, using groups as the controlling variable and controlling for baseline values recorded at time point 1. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The baseline versus after the intervention adherence score was 2.05 (SD 1.45) versus 1.72 (SD 1.99) in CG and 1.65 (SD 1.80) versus 1.76 (SD 1.64) in IG; P= 0.376. The difference in mean change scores (95% CI) was reported as –0.388 (–1.27, 0.493); P= 0.376. The mean seizure occurrences between the control and intervention groups were 12.71 (SD 24.55) and 6.76 (SD 13.40). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0006" title="HelgesonDC , MittanR , TanSY , ChayasirisobhonS . Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia1990;31(1):75-82. [DOI: 10.1111/j.1528-1157.1990.tb05363.x] [PMID: 2303015]">Helgeson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood test measuring serum drug level was used to assess adherence with medication. The following measurements were also performed: level of anxiety was assessed by STAI, WPSI, AD scale, Sherer’s Self‐Efficacy Scale and epilepsy knowledge and medical management 50‐item true‐false questionnaire </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeated ANOVa measures and a series of paired t‐tests</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percentage change scores in blood AED levels (adherence) in the intervention group increased significantly F(1,24) = 4.18, P &lt; 0.05. The treatment group showed a significant decrease in level of fear of death and brain damage due to seizures, F(1,36) = 7.49 (P = 0.009) and a significant decrease in hazardous medical self‐management practices, F(1,36) = 29.67 (P = 0.0001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0007" title="IbindaF , MbubaCK , KariukiSM , ChengoE , NgugiAK , OdhiamboR , et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia2014;55(2):344–52. [DOI: 10.1111/epi.12498] [PMID: 24447063]">Ibinda 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in adherence to AEDs was assessed by self‐report using the 4‐item MMAS. Plasma drug concentrations were measured using a fluorescence polarisation immunoassay analyser (TDxFLx Abbott Laboratories)<br/>Epilepsy beliefs were measured using KEBAS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pearson’s Chi<sup>2</sup> test, modified Poisson regression t‐tests and logistic regression. All statistical analyses were performed using STATA (version 12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference in adherence to AEDs was noted between the 2 groups based on self‐reports (OR 1.00, 95% CI 0.71 to 1.40; P = 1.00) or in detectable drug levels (OR 1.46, 95% CI 0.74 to 2.90; P = 0.28). No difference in seizure frequency was found between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0010" title="ModiAC , GuilfoyleSM , RauschJ . Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. Journal of Pediatric Psychology2013;38(6):605–16. [DOI: 10.1093/jpepsy/jst021] [PMID: 23613481]">Modi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers completed baseline questionnaires and all families were provided with MEMS‐6 Track‐Cap to monitor adherence. Caregivers (intervention group) also completed several questionnaires: psychosocial (e.g. QoL), epilepsy knowledge, social problem‐solving skills, epilepsy medication management, feasibility‐acceptability questionnaire, medical chart review and background information form </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Means, SDs and frequencies were measured using IBM SPSS statistics software (version 20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean percentage change in adherence from baseline to post‐intervention was 31.5 (SD 52.9) for the intervention group and 9.3 (SD 8.7) for the control group (no significance levels were reported). The impact on quality of life due to the implementation of the intervention reported a significant benefit (mean 6.75 (SD 0.6)). Other outcomes measured included assessment of feasibility and acceptability of the adherence intervention. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0012" title="ModiAC , GuilfoyleSM , MannKA , RauschJR . A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia2016;57(3):e69–e75. [DOI: 10.1111/epi.13289] [PMID: 26693964]">Modi 2016b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adherence, MEMS TrackCap (Aardex Corporation)</p> <p>For secondary outcomes: EKQ; Social Problem‐Solving Iventory‐Revised; Parent response to child illness </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A repeated‐measures model based on maximum likelihood estimation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence score (weeks 4–6; TAU = 12.0 vs STAR (intervention group) = 18.1, P &lt; 0.01; and weeks 6–8: TAU = 9.7 vs STAR = 15.3, P &lt; 0.05). During the 3‐month follow‐up period, no significant group differences were found on AED adherence. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0015" title="Pryse-PhillipsW , JardineF , BurseyF . Compliance with drug therapy by epileptic patients. Epilepsia1982;23(3):269-74. [DOI: 10.1111/j.1528-1157.1982.tb06191.x] [PMID: 7084138]">Pryse‐Phillips 1982</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum drug levels of phenobarbitone, phenytoin, carbamazepine, sodium valproate, and ethosuximide were performed using a gas liquid chromatograph or by the EMIT method on each occasion where relevant. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparisons of means in paired samples, Student’s t‐test, correlation coefficients, and linear regressions were performed using an IBM computer </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The results show whether information was given in oral form alone or both orally and in written form; adherence to drug treatment as measured by serum levels was not improved. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0016" title="MagillN , RidsdaleL , GoldsteinLH , McCroneP , MorganM , NobleAJ , et al. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials2015;16:269. [DOI: 10.1186/s13063-015-0788-9] [PMID: 26068449]RidsdaleL , McKinlayA , WojewodkaG , RobinsonEJ , MosweuI , FeehanSJ , et al. Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial. Health Technology Assessment2018;22(21):1-142. [DOI: 10.3310/hta22210] [PMID: 29717699]RidsdaleL , WojewodkaG , RobinsonEJ , NobleAJ , MorganM , TaylorSJ , et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia2018;59(5):1048–61. [DOI: 10.1111/epi.14073] [PMID: 29658989]">Ridsdale 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For QoL: QOLIE‐31‐P with added patient‐specific weightings.</p> <p>For adherence, Medication Adherence, a 10‐item subscale from ESMS</p> <p>Other outcomes assessed using seizure frequency scales, seizure recency (number of days since last seizure), HADS<br/>for psychological distress (anxiety and depression), Impact of Epilepsy, Stigma of Epilepsy, medication adverse effects extracted from the QOLIE‐31‐P, and self‐mastery and control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All outcomes were analysed using the ITT approach. Linear mixed regression model was used for analysis of primary and secondary outcomes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 12‐month follow‐up, the medication adherence score median (IQR) for intervention was 47.8 (IQR 45.6 to 48.9; range 27.8 to 50.0) versus 47.8 (IQR 45.6 to 48.9; range 35.6 to 50.0) in the TAU group. </p> <p>There were no statistically significant differences between trial arms in QOLIE‐31‐P (intervention mean 67.4, SD 13.5; control mean 69.5, SD 14.8). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0017" title="SaengowVE , ChancharoenchaiP , SaartyingW , PimpaW , ChotichanonN , LewsiriratT , et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clinical Neurology and Neurosurgery2018;172:59-61. [DOI: 10.1016/j.clineuro.2018.06.031] [PMID: 29986196]">Saengow 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using the MMAS‐8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pearson’s correlation, t‐test, Fisher Exact test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At baseline, the mean scores of knowledge questionnaire</p> <p>was lower in intervention (6.73) compared with control (7.48). After the video animation, intervention group mean score increased (7.42; P &lt; 0.001) and at the 3‐month follow‐up (7.47). There were slight score changes at 3‐time point in control group (7.48,7.53, 7.44). </p> <p>The proportion of participants with improved adherence was 54 (42.9%) in intervention versus 14 (15.9%) in control group P &lt; 0.001 </p> <p>Proportion of participants with improved severity of seizure higher in intervention 47 (37.3%) than control group 22 (25.0%) in CG, P = 0.14. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0018" title="ShopeJT . Intervention to improve compliance with pediatric anticonvulsant therapy. Patient Counselling and Health Education1980;2(3):135-41. [DOI: 10.1016/s0738-3991(80)80056-5] [PMID: 10249191]">Shope 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed by measurement of serum drug levels using blood tests</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANOVA, ANCOVA and Chi<sup>2</sup> tests were performed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean score of the intervention group on the combined adherence score was 2.9, which is significantly higher than the mean score in the control group 2.2 (F(1,48) = 6.36, P = 0.015). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0020" title="ZhengY , DingX , GuoY , ChenQ , WangW , ZhengY , et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy &amp; Behavior2019;100(Pt A):106400. [DOI: 10.1016/j.yebeh.2019.07.001 ] [PMID: 31634729]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed using MMAS‐8, other measures included Beck Depression Inventory, Beck Anxiety Inventory, QOLIE‐31 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>t<i>‐</i>test and Mann‐Whitney test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased number of participants with moderate‐to‐high AED adherence (71 (77.2%) vs 56 (60.9%); P =0.006). </p> <p>The intervention group showed improvements in 5 of the 7 subscales in QOLIE‐31, overall QoL (74.1 ± 15.0 vs 63.2 ± 14.6; P = 0.010), emotional well‐being (81.3 ± 16.2 vs 69.0 ± 15.5; P = 0.006), energy (74.8 ± 18.2 vs 63.4 ± 17.0; P = 0.013), cognitive function (77.7 ± 20.4 vs 66.5 ± 19.3; P = 0.011), and social function (72.0 ± 22.7 vs 61.8 ± 21.6; P = 0.015). The control group showed improvements in only 3 aspects; seizure worry (51.0 ± 32.7 vs 46.1 ± 30.0; P = 0.038), emotional well‐being (68.7 ± 22.1 vs 67.8 ± 21.1; P = 0.007), and medication effect (52.1 ± 36.3 vs 47.8 ± 34.4; P = 0.015). Proportion of participants with a low seizure frequency increased in both the intervention group (70 (76.1%) vs 41 (44.6%); (P= 0.001) and the control group (74 (80.4%) vs 50 (54.3%); P = 0.001) however, the difference between the 2 groups, is not significant (80.5% vs 76.1%; P = 0.475). A reduction of number of participants with severe depression and anxiety. </p> </td> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Mixed interventions</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>References</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assessment methods</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Statistical analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0008" title="LeenenLA , WijnenBF , KesselsAG , ChanH , deKinderenRJ , EversSM , et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy &amp; Behavior2018;80:259-65. [DOI: 10.1016/j.yebeh.2018.01.019] [PMID: 29449140]WijnenBF , LeenenLA , deKinderenRJ , vanHeugtenCM , MajoieMH , EversSM . An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia2017;58(8):1398–408. [DOI: 10.1111/epi.13806] [PMID: 28589669]">Leenen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adherence, MEMS (Aardex) and MARS‐5.</p> <p>Other outcomes were self‐efficacy and general self‐efficacy (disease‐specific self‐efficacy (ESES and GSES), seizure severity NHS3); emotional well‐being (HADS); QoL (QOLIE‐31P); proactive coping (Utrecht Proactive Coping Competence); and side‐effects of antiepileptic drugs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The baseline differences between the multicomponent self‐management intervention group and TAU group were analysed using independent t‐tests </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with epilepsy lost to follow‐up or who did not use the cap at all, were considered nonadherent. Adherence rates of those included in the MEMS analysis over 6 months were 63.7% for the CAU group and 75.9% for the intervention group; the difference was not statistically significant. </p> <p>Adherence score over 6 months were 23.7 (1.3) for the CAU group and 23.9(0.9) for the intervention group; the difference was not statistically significant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0009" title="LiJ , SiY , HuJ , LiuL , DengY , HeJ , et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia2013;54(11):1988–96. [DOI: 10.1111/epi.12382] [PMID: 24117425]">Li 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To assess drug adherence, 6‐response‐option rating scales were applied. With regard to lifestyle or habits, 6 similar ratings were used to measure frequency of seizure‐provoking events. The subsequent seizure assessment for intervention group was obtained from the epilepsy tracking card. </p> <p>In control group medical adherence ratings were derived from self‐reported data and calculated AED adherence by counting the remaining pills to count the number of missed doses </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chi<sup>2</sup> test, or correlated Chi<sup>2</sup> test or Fisher’s exact test and one‐way ANOVA were used to conduct statistical analyses with SPSS (version 17.0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence improved in the intervention group, as most members (142 (77.6%) compared to 17 (9.6%)) rated their adherence as excellent or very good, but it remained nearly unchanged in the control group. </p> <p>A moderate correlation was found between the changes in AED adherence and seizure control (r = 0.4, P &lt; 0.05), and a weaker correlation was found between lifestyle and seizure control (r = 0.328, P &lt; 0.05). The percentage of participants reported a reduction in seizures in at least 50% (including those who were seizure‐free) rose to 79.8% in the intervention group, compared to 61.0% in the control group (P &lt; 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0014" title="PetersonGM , McLeanS , MillingenKS . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia1984;25(4):412-7. [DOI: 10.1111/j.1528-1157.1984.tb03436.x] [PMID: 6430689]">Peterson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was assessed by changes in plasma anticonvulsant levels (provided that the participant's medication regimen had not been altered in the preceding 2 weeks), a check of the participant's prescription record book to determine prescription refill frequency, medication seizure diary (to record Dosett container check) and participant appointment‐keeping frequency (those who had attended all scheduled appointments in the previous 6 months were considered compliant) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>McNemar tests for related samples, Wilcoxon matched‐pair tests, Stuart‐Maxwell tests, and Student’s paired t‐tests,<br/>Chi<sup>2</sup> tests, Mann‐Whitney tests, and Student’s unpaired t‐tests </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study shows that adherence (mean plasma levels) can be improved and seizure frequency lessened by compliance‐improving intervention. Although the differences between the 2 groups in mean anticonvulsant dosages were not statistically significant, they might be clinically important. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008312-bbs2-0019" title="TangF , ZhuG , JiaoZ , MaC , ChenN , WangB . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy &amp; Behavior2014;37:157–64. [DOI: 10.1016/j.yebeh.2014.05.017] [PMID: 25022824]">Tang 2014</a> </p> <p>(This study is presented in this review as both educational and mixed interventions)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was measured using the</p> <p>MMAS‐4; seizure control was reported according to the participants’ records and telephone follow‐ups by the pharmacist; a questionnaire was developed to evaluate the level of each participant's knowledge of AEDs; QOLIE‐31 was used to measure QoL.<br/>Adherence, knowledge of AEDs, number of seizures and other measures were evaluated at the beginning and at the end of follow‐up. QoL was only measured after intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All analyses were performed using the IBM SPSS statistics (version 19). Tests such as Pearson's Chi<sup>2</sup> tests, student's t‐tests and Mann–Whitney U test were performed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The adherence and knowledge of AEDs increased greatly after intervention in all participants, the number of seizures and missed dosages also decreased. However, no significant differences were observed between 2 groups: increased adherence (62.3% vs 64.3%, P = 0.827); increased knowledge of AEDs (88.7% vs 80.4%, P = 0.231) and improved seizure control (64.2% vs 64.3%, P = 0.988). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>AD:</b> Acceptance of Disability; <b>AED:</b> antiepileptic drug; <b>AGAS:</b> Antiretrovial General Adherence Scale; <b>ANCOVA:</b> analyses of co‐variance; <b>ANOVA:</b> analysis of variance; <b>BIPQ:</b> Brief Illness Perception Questionnaire; <b>CD‐RISC:</b> Connor‐Davidson resilience scale; <b>CI:</b> confidence interval; <b>EKQ:</b> Epilepsy Knowledge Questionnaire; <b>EKP:</b> Epilepsy Knowledge Profile; <b>EMIT:</b> enzyme‐multiplied immunoassay technique; <b>ESES:</b> Epilepsy Self‐Efficacy Scale; <b>ESI‐R:</b> Revised Epilepsy Stressor Inventory; <b>ESMS:</b> Epilepsy Self‐Management Scale; <b>GSES:</b> General Self‐Efficacy Scale; <b>HADS:</b> Hospital Anxiety and Depression Scale; <b>HRQoL:</b> health‐related quality of life; <b>KEBAS:</b> Kilifi Epilepsy Beliefs and Attitudes Scores; <b>LSSS:</b> Liverpool Seizure Severity Scale; <b>MARS:</b> Medication Adherence Report Scale; <b>MAS:</b> Medication Adherence Scale; <b>MASQ:</b> Multiple Ability Self Report Questionnaire; <b>MEMS:</b> Medication Event Monitoring Systems; <b>MMAS:</b> Morisky Medication Adherence Scale; <b>NHS3:</b> National Hospital Seizure Severity Scale; <b>OR:</b> odds ratio; <b>PRMQ:</b> Prospective and Retrospective Memory Questionnaire; <b>PSQI:</b> Pittsburgh Sleep Quality Index; <b>PSS:</b> Perceived Stress Scale; <b>QoL:</b> quality of life; <b>QOLIE:</b> Quality of Life in Epilepsy Scale; <b>SD:</b> standard deviation; <b>SF‐12:</b> Short‐Form 12‐question health survey; <b>STAI:</b> State‐Trait Anxiety Inventory, State Annxiety Scale; <b>SWLS:</b> Satisfaction with Life Scale; <b>TAU:</b> treatment as usual; <b>TPB:</b> Theory of Planned Behaviour; <b>WPSI:</b> Washington Psychosocial Seizure Inventory </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of results for each included study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008312.pub4/full#CD008312-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008312.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008312-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008312-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008312-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008312-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD008312-note-0011">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD008312-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD008312-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008312-note-0014">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD008312-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD008312-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008312-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008312\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008312\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008312\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008312\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008312\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008312.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008312.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008312.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008312.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008312.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719983183"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008312.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719983187"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008312.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df60fcf249368',t:'MTc0MDcxOTk4My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 